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DENDRITIC CELLS AND CD4 T CELLS: DUAL ROLES IN THE CLEARANCE 
AND PATHOGENESIS OF HERPES SIMPLEX VIRAL INFECTION 
 
Gregory Frank, Ph.D. 
University of Pittsburgh, 2009
 
 
Herpes Stromal Keratitis (HSK) is one of the leading causes of infectious blindness in the 
developed world.  HSK is characterized by corneal damage and scarring that results from a Th1 
cytokine-mediated immunopathology.  It is triggered by reactivation of HSV-1 from latency in 
sensory neurons of the trigeminal ganglion (TG) and its subsequent transport to the eye through 
axons that innervate the cornea.  My thesis work explored key components of both the HSV-
specific CD8+ T cell response that maintains HSV-1 latency in sensory neurons, and the 
opposing roles of the immune system in controlling HSV-1 replication in the cornea and 
promoting the immunopathology that results in corneal scarring and blindness.  We hypothesized 
and provide strong supporting evidence that CD4+ T cells act as a double-edged sword, on the 
one hand providing critical help to HSV-specific CD8+ T cells that enables them to control viral 
latency through avoidance of exhaustion within the infected TG.  On the other hand, we 
employed HSV-specific CD4+ T cell clones to explore their role in orchestrating the 
immunopathology associated with HSK.  We also explored the Ying and Yang of dendritic cell 
involvement in HSK.  While our previous studies suggested a role for DC in promoting HSK, we 
now employ a unique localized DC depletion model to establish that “first responding” DCs are 
critical in mobilizing both the innate and adaptive immune response that clears virus from the 
cornea.  Finally, we employed newly available recombinant mouse strains lacking IL-12p40, 
p35, or both p40 and p35 to explore the involvement of the IL-12 cytokine family in HSK.  The 
 iv 
heterodimeric cytokines IL-12 (p40/p35) and IL-23 (40/p19) are thought to regulate HSK by 
promoting production of the requisite TH1 cytokine IFN-γ.  However, we find that HSK 
development does not require IL-12p40 and is thus independent of IL-12 and IL-23. Instead, 
HSK late progression actually requires a previously unrecognized IL-12p40-independent, 
proinflammatory function of IL-12p35.   
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1.0  INTRODUCTION 
1.1 HERPES SIMPLEX VIRUS TYPE 1 
1.1.1 Epidemiology  
The human herpesvirus family represents a group of structurally similar viruses that incur a 
considerable burden on health care systems throughout the world.  In the United States the 
seroprevalence of herpes simplex virus type-1 (HSV-1) has been estimated at 58% of the total 
population, while other developed nations report an incidence of HSV-1 infection as high as 75% 
(1,2). Although HSV-1 seropositivity varies by age and is influenced by a variety of risk factors, 
these studies nevertheless clearly demonstrate that HVS-1 is a ubiquitous infectious agent 
throughout the world (3-5).   
HSV-1 predominately infects the orofacial region, where the primary infection tends to 
be asymptomatic; the most common manifestation is the cold sore. Of note is the ability of HSV-
1 to infect the sensory nerve termini innervating the site of infection, travelling up to the neuron 
cell bodies, where it establishes latency. Latency is a quiescent state defined as the presence of 
viral genome within the host neuron in the absence of infectious virions (6).  Within certain host 
neurons HSV-1 may reactivate and shed virus back down to the original site of infection. While 
often asymptomatic, shed virus can lead to a broad range of clinical entities, such as herpes 
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labialis, gingivostomatitis, endophthalmitis, and the potentially fatal encephalitis.  Of greater 
interest to our lab is the complication of recurrent HSV-1 corneal infection called herpes stromal 
keratitis (HSK), which is the leading infectious cause of blindness in the United States, as well 
and a leading indicator for penetrating keratoplasty (7-9). 
Therapeutic approaches to HSV-1 are compounded by the ability of the virus to establish 
latency, which in turn renders the virus difficult to eradicate once latent infection has been 
established.  At this time there are no effective vaccines which can prevent HSV-1 infection, or 
its subsequent reactivation from latency (4).  Current treatments now consist of antiviral drugs, 
such as acyclovir, which are capable of selectively inhibiting viral DNA synthesis (10).   
1.1.2 Viral Structure 
HSV-1 is a double stranded DNA virus comprised of 4 distinct components.  The innermost 
component is the viral genome, which is approximately 152 kilobases in size, and encodes 84 
viral proteins (11).  The second component, the capsid, is an icosadeltahedral structure of viral 
proteins that encase the viral genome.  The third element is the tegument, an amorphous layer of 
various proteins that are needed for wresting control of host transcriptional machinery and 
initiation of viral transcription upon host cell infection.  The final component is the lipid bilayer 
envelope, which is acquired from host cell membrane during viral egress.  The envelope is also 
studded with a number of viral glycoproteins with established functions in both viral egress and 
entry (12), (Figure 1). 
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Figure 1 - Depiction of viral structure and morphology.  
On the left is an electron micrograph of an intact viral particle.  The right illustration depicts a schematic of 
the viral components in relation to the electron micrograph. Adapted from Todar, K. 2009. Online Lecture. 
1.1.3 HSV-1 life cycle: Lytic Infection and Latency 
Upon primary lytic infection, HSV-1 genes are expressed in a highly regulated sequential fashion 
(figure 2).   These genes fall into three classifications, each group contributing a unique function 
towards the formation of new infectious virions (table 1).  
        
Figure 2 – Depiction of sequential activation of HSV-1 gene products 
This figure illustrates the sequential activation of genes upon HSV-1 infection of a host cell.   
              Courtesy of Brian Sheridan, Ph.D. 
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 Table 1 – Brief classifications of the sequential HSV-1 genes  
Class Kinetics of transcription Functions 
Immediate Early (α)  Without host de novo protein synthesis 
Transactivate β and γ gene transcription; 
repress host and α gene transcription; 
immune evasion 
Early (β) 
After de novo protein 
synthesis, prior to DNA 
replication 
DNA replication machinery  
Leaky-Late (γ1) 
Initiated prior to DNA 
replication, majority 
transcribed after 
Virus attachment and assembly; tegument 
proteins 
True-Late (γ2) Requires DNA replication for transcription 
Capsid assembly; virus attachment; 
tegument proteins 
 
 As depicted in the table above, the first gene products expressed by HSV-1 upon lytic 
infection are the immediate early (IE), or α-genes.  These genes are expressed within one to two 
hours of initial infection, and do not require de novo viral protein synthesis.  The IE genes 
encode six proteins: ICP0, ICP4, ICP22, ICP27, ICP47, and Us1.5.  All IE proteins except ICP47 
play a role in the transactivation of viral transcription, with ICP0, ICP4, and ICP24 being the 
most critical to this process. 
 The IE proteins transactivate the second group of viral genes, the early (E) or β-genes.  
These genes, normally expressed between four and eight hours after infection, function to initiate 
viral DNA replication, a process which is needed to activate the Late, or γ genes.  The γ-genes 
are further subdivided into two groups, the “leaky-late” γ1 genes and the “true-late” γ2 genes.  
The γ1 genes, such as glycoprotein B (gB) are expressed at low levels prior to DNA replication, 
after which they increase exponentially in expression.   The γ2 genes only expressed following 
viral DNA synthesis.   Collectively, these γ-genes primarily encode the structural proteins 
required for final viral assembly.  The newly formed virions upon assembly egress from the cell, 
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thus completing what is described as the lytic infection pathway, so called as it inexorably leads 
to host cell death.  
 HSV-1 can also assume a latent lifestyle in which viral genome can persist for prolonged 
periods without virion formation or destruction of the host cell.  Latency is established in vivo 
when the neurotropic HSV-1 infects a sensory neuron innervating the site of primary infection.  
The exact processes that drive HSV-1 from a lytic path to latency are not well understood. Some 
research suggests the quiescent nature of the neuron as well as certain neuron specific proteins 
may play a role in divergence into this dormant state (13,14).  This is a relatively stable process, 
as individuals retain latent HSV-1 within their sensory neurons for life.  While no viral proteins 
are detected during HSV-1 latency, latency associated transcripts (LAT) were  discovered in 
latently infected neurons (15-17).  Much research has been expended establishing the function of 
these unique transcripts.  However a large body of work has found that LATs are not absolutely 
critical for the establishment of, or reactivation from latency (18-20).  Other studies have 
established a role of LATs in promoting neuron survival by protecting the neurons from 
apoptosis (21,22).   Recent evidence has also found LATs help determine the propensity of how 
HSV-1 establishes in certain neuronal subsets (23).  A final group of studies found microRNAs 
are encoded by the LAT gene, and these function to impair ICPO protein expression, providing a 
level of control of reactivation under certain conditions (24).   
 The underpinnings of how HSV-1 transitions from latency back to a productive lytic 
infection are poorly understood at best.  The process of reactivation ultimately leads to the 
release of transmissible viral particles back down to the primary site of infection.  Certain 
conditions, such as immunocompromise, UV-B irradiation, physical stressors such as 
hypothermia and invasive surgery, and psychological stress have all been associated with an 
 5 
increase in reactivation from latency (25-31).  While the dogma previously forwarded that these 
insults lead to reactivation solely by directly changing the neuron’s physiology, recent work by 
this lab and others have actively promoted an additional role for the immune response in 
retaining HSV-1 in latency, and that many of these stressors impact the immune system.   
1.2 THE CORNEA 
1.2.1 Structure of the cornea 
As our lab and this research focuses on ocular HSV-1 infection and its subsequent transition into 
HSK, a brief overview of the structure of both the eye and cornea are required.  The cornea is a 
critical component of the eye whose function, in conjunction with the lens, refracts light to the 
retina.  The cornea consists of three sections, as described in figure 3.   The outermost layer, the 
epithelium, consists of seven to nine actively dividing cells.  Its primary function is to provide a 
mechanical barrier that protects the eye from foreign objects as well as to water and to create a 
surface with promotes the retention and absorption of tear film (32).  Immediately below the 
epithelium is the bowman’s layer, a thin but dense layer of collagen which both protects and 
retains the shape of the underlying corneal stroma (33,34).  The third and largest layer is that of 
the corneal stroma, the main refractive element of the cornea. The stroma contains an extremely 
organized system of collagen fibers which are bundled into structures called  
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 Figure 3 – basic anatomy of the cornea 
Illustration depicting the five distinct layers of the cornea strata.  Moving anterior to the posterior 
as follows: epithelium, bowman’s layer, stroma, Descemet’s membrane, and endothelium. 
Adapted from Gray’s Anatomy (public domain image). 
 
Lamellae (35,36).  The lamellae are organized in a parallel fashion to the corneal epithelium, 
running from the one side of the cornea to another.  These fibers run in superior to inferior or 
nasal to temporal fashion, and can interweave over each other.  This organization of the lamellae 
provides the unique transparent nature and refractive power of the cornea.  Interspersed between 
the lamellae are keratocytes, which function to maintain the organization to the corneal matrix.  
Following injury, these cells have been implicated in scar formation as they turn into corneal 
fibroblasts (37).  Below the stroma lies Descemet’s membrane, which functionally is closely 
associated with the endothelial layer.  It consists of a thin layer collagen, though a different type 
from the lamellae within the cornea.  This collagen layer is secreted by the underlying 
endothelial cells.  The endothelial layer is a monolayer of non-dividing cells bathed in the 
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aqueous humor of the anterior chamber.  The endothelium within the eyes serves to pump waste 
and excess water from the overlying corneal cells into the aqueous humor as well as actively 
transport vital nutrients to maintain these cells (38,39).   
As one views the cornea face on, one can see the corneal stromal bed interfaces with the 
conjunctiva around the periphery of the cornea (figure 4).  The conjunctiva is a highly 
vascularized bed of tissue, but blood vessels terminate abruptly at the stromal interface. 
 
Figure 4 – Corneal Stroma is Asvascular 
Photograph of a human cornea.  C represents the cornea stroma, while CJ represents the 
conjunctiva.  The stars mark the abrupt end of blood vessel infiltration at the interface between 
the two tissues.  Adapted from Ambat et al. 2006. Nature 
 
As the endothelial cells provide the necessary mechanism to remove waste and provide 
nutrients to the corneal bed, it is not reliant on vasculature for tissue survival.  This is allows the 
cornea to remain devoid of vessels, thus allowing the tissue to remain perfectly transparent.  
Until recently, it was not well understand how the cornea was capable of retaining its avascular 
nature when surrounded by the heavy vascularized conjunctiva, and even more so as vascular 
endothelial growth factor (VEGF, a potent inducer of neovascularization) is found within the 
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cornea.  However a recent study observed this VEGF is bound by soluble VEGF-receptor, 
produced constitutively within the cornea bed (40).  This sequesters VEGF from exerting its 
function, thus retaining the avascularity of the cornea. 
1.2.2 The immune privilege of the cornea 
While the unique ability of the cornea to remain avascular helps maintain its organized structure 
for visual acuity, it also provides an important advantage by allowing the cornea to remain 
immune privileged.  Immune privilege is historically defined as a site that can tolerate an 
introduction of a foreign antigen without generating an inflammatory response.  This allows the 
corneal architecture so important for vision to remain organized.  Much of the knowledge of the 
cornea’s immune privilege comes from corneal transplantation studies, where grafts placed into 
the avascular bed enjoy a very high acceptance rate (41,42).  Indeed, a number of anti-
inflammatory mechanisms, such as transforming growth factor β (TGF-β), Fas Ligand, and α-
melanocyte-stimulating hormone (α-MSH) have been discovered to operate within the anterior 
chamber of the eye (43-46).   
Previously, it was thought that avascular nature of the cornea corresponded to a lack of 
immune cells, such as antigen presenting cells (APCs) within the cornea.  While some studies 
had reported CD11c+ dendritic cells (DCs) within the corneal stroma, others have observed 
conflicting results (47-49).  Recent work by our lab and others has discovered that immune 
populations are in fact present within the cornea (our unpublished observations), (49,50).  These 
populations of APCs are sparse, and appear to be closely interfaced with the epithelium, actually 
residing in the basement membrane, not the corneal stroma.  It is unknown at this time whether 
these cells within the cornea function identically to their counterparts elsewhere in the body (i.e. 
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promote an inflammatory response), or if they have specialized functions within the cornea.  
Additional research on the role of these resident cells is needed to further our understanding of 
the complex immune privilege qualities of the eye. 
1.3 THE IMMUNE RESPONSE: CONTROL OF OCULAR HSV-1 INFECTION 
1.3.1 The Innate Immune Response 
1.3.1.1 First responders of the innate Immune response 
Upon initial encounter with a pathogen, the body’s innate immune system mobilizes rapidly to 
control the primary infection.  In the model of ocular HSV-1 infection, virus begins lytic 
replication within the epithelium of the cornea.  This elicits the first line of intrinsic defense 
mechanisms within the cornea, Type I interferons (51).  These soluble factors play a role in 
mobilizing both the infected cells as well as its neighbors to resist viral replication, upregulate 
MHC class I machinery, as well as invoke the infiltration of innate responders.  Studies 
observing the innate immune response to ocular HSV-1 infection  identified polymorphonuclear 
(PMN) neutrophils, natural killer (NK) cells, and γδ TCR cells important in initial control of 
virus (52-55).  In the face of the innate immune system’s efforts, HSV-1 nevertheless gains 
access to the nerve termini at the corneal epithelium, and travel by retrograde axonal transport to 
the trigeminal ganglion (TG), the common sensory nerve trunk that innervates the orofacial 
region.  This process normally occurs very rapidly after primary infection, with virus reaching 
the TG within 24-48 hours (56).   
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The innate immune response also plays a critical role within the TG before the adaptive 
immune system is sufficiently mobilized.  Macrophages and γδ TCR cells infiltrate the TG soon 
after viral access.  The infiltrating macrophages play an antiviral role through nitric oxide (NO) 
and tumor necrosis factor (TNF) while the γδ T cells help limit viral spread through type II 
interferons (IFN-γ) (52,57-59).  Thus the innate immune response effectively limits viral spread 
within the ganglion.  However the innate immune system is unable to completely eradicate HSV-
1 from either the cornea or the TG, only containing viral replication while the adaptive immune 
response is marshaled within the lymphoid tissues draining the site of infection.  
1.3.1.2 Dendritic cells  
Arguably one of the most important cells within the innate immune response is the dendritic cell 
(DC).  These cells are present throughout the body, and serve as sentinels, surveying foreign 
particles that body comes into contact with.  They play integral roles in helping both the innate 
and adaptive immune response mobilize properly to infection.  DCs are a very heterogeneous 
population, greatly complicating classification.  However recent attempts have broadly classified 
DCs into two groups: classical DCs (myeloid lineage DCs) and plasmacytoid DCs (lymphoid 
lineage).  Further subdivisions can be made of these groups for the purposes of HSV-1 infection 
as described in table 2. Plasmacytoid DCs (pDCs) are characterized by their non-myeloid lineage 
as well as being potent producers of type one interferons (60).  Classical DCs (cDCs) are 
phenotypically identified CD11c+CD11b+ and, and largely comprise of two sets (CD8α+ and 
CD8α-) and are thought to be the primary lymphoid antigen presenting cells to T and B cells.  
Langerhans cells are a subset of cDCs that are located within the epidermis of the skin (61).  
 11 
These cells are thought to be important peripheral sentinels that acquire and transport viral 
antigen for presentation in the lymphoid tissues. 
 
 
Table 2 – Selected dendritic cell subsets – phenotypic markers and basic functions  
Class Phenotypic markers Functions 
Plasmacytoid DCs (pDC) CD317, GR-1, CD11c
low, 
CD11blow 
Potent producers of IFN-α/β: 
antiviral functions 
Classical DCs (cDC) CD11c, CD11b, CD8α+ OR - 
Presentation of antigen within the 
DLN to T cells and B cells 
Can infiltrate peripheral sites for 
local costimulation   
Langerhans cells (LC) 
(Epidermal DCs) 
Langerin, Birbeck granules, 
CD11clow  
Peripheral acquisition of antigen – 
indirect transportation to DLN 
Potential immunomodulatory role 
 
While the role of DCs within the cornea has not been completely elucidated, studies 
abound concerning the function of these cells in response to HSV-1 infection in other peripheral 
sites.  The classic dogma of DCs during the steady state is that of an actively phagocytic stance, 
constantly sampling potential antigens from their surroundings.  However when a DC comes into 
contact with a pathogen, it is able to recognized pathogen associated molecular patterns 
(PAMPS), which are unique bacterial and viral components not shared with any cells within the 
body (62,63).  This drives the DC to undergo a maturation process, which upregulates the MHC-
II and costimulatory molecules on the DC, and also promotes its egress out of the peripheral 
tissue.  DCs exit peripheral tissue via the lymphatic system, which drains into the lymph nodes 
(DLN) where they are the lynchpin of generating an adaptive immune response.   
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Work by Carbone et al examined DCs in response to flank infections of HSV-1 and have 
found more complex relationships exist in how DCs transport and present antigens to the 
adaptive arm of the response.  Studies have found that LCs do not actually present antigen to T 
cells, but “hand off” antigen to CD8α+ cDCs which go on to present the antigen (64). A further 
example is the observations of distinct functional roles of Langerhans cells that reside in 
different layers of the skin.  Epidermal resident LCs tend to play an immunomodulatory role, 
while dermal resident LCs play the more classical role in mobilizing the immune response 
(65,66).  This raises the possibility that local resident DCs may play a different role in the 
immune response to HSV-1 versus those that may migrate into the infected cornea in response to 
danger signals.   Further studies have also observed differential migratory and presentation of 
DC subsets in response to HSV-1, suggesting a more complex interplay of the heterogeneous DC 
population in activating the adaptive arm then previous considered (67,68). 
DCs also play key roles in the innate immune response to viral infection.  As stated 
above, the specialized pDC subset plays a key role in anti-viral cytokine production in response 
to virus associated PAMPS.  cDCs have also been identified to play a role in helping to 
mobilizing the innate immune response.  A large body of work observed a critical function of 
DC produced IL-15 in helping to activate NK cell cytotoxic functionality (69-71).  Thus 
dendritic cells play important roles in bringing both the innate and adaptive arms of the immune 
response to bear on vial pathogens such as HSV-1. 
1.3.2 Initiation of the Adaptive Response 
In order to completely control HSV-1 infection, the adaptive arm must be marshaled.  The 
adaptive immune system can be broadly defined into both B and T cells.  B cells, upon activation 
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with their cognate antigen produce HSV-1 neutralizing antibodies, which play a role in 
combating viral spread.  T cells can be further broken into two major sub-groups based on the 
coreceptor CD4 and CD8.   
1.3.2.1 CD4+ T  cells  
CD4+ T cells often referred to as T helper cells, play a role in activating and promoting the 
survival of other immune cells.  CD4+ T  cells play a vital role in activating B cell antibody 
isotype switching, and also activate macrophages, increasing their phagocytic and anti-viral 
functions (72,73). CD4+ T cells can be further broken up into four functionally distinct groups 
based on the milieu of cytokines present at the time of TCR engagement (Figure 5).  
 
Figure 5 – T helper subsets and the factors that drive their differentiation 
Illustration of the factors that drive a naïve T cell into its lineage.  IL4 drives TH2 differentiation, 
IL-12 drives TH1 differentiation, TGF-β and IL-6 drive TH17 differentiation, and TGF-β alone 
can convert a CD4+ T cell into a T-reg. Please note how cytokines produced by certain helper 
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subsets suppress the differentiation of naïve T cells into competing lineages. Adapted from 
Jetton AM. 2009. Nuclear Receptor Signaling. 
 
TH1 cells produce IFN-γ and IL-2 and orient the immune response to fight intracellular 
pathogens.  This is the predominant T helper subset generated in response to ocular HSV-1 
infection.  TH2 cells produce IL-4, IL-5, and IL-13 and play a role in mobilizing the immune 
system to combat extracellular pathogens (74).  TH17 cells are characterized by IL-17 
production, and have potent inflammatory functions, and are implicated in a number  of  
immunopathologies such as rheumatoid arthritis and colitis (75).   The final subset, T-regulatory 
cells, suppresses immune responses through a variety of cytokines and surface receptors such as 
TFG-β, IL-10, galectin, and CTLA-4 (76-78).  These cells are defined phenotypically by the 
receptor CD25 and the transcription factor FoxP3. 
1.3.2.2 CD8+ T  cells 
CD8+ T cells are one of the main tools in the immune system’s arsenal against intracellular 
infections such as HSV-1, and correspondingly the most important component of the adaptive 
immune response to HSV-1 ocular infection.  Indeed, in murine models deficient in CD8+ T  
cells, HSV-1 replication is not fully controlled within the TG, often leading to fatal encephalitis 
(79,80).  The hallmark of the CD8+ T  cell is its ability to kill virally infected cells; due to this 
designation, CD8+ T  cells are sometimes referred to as cytotoxic T lymphocytes (CTLs) (81).  
The most well established method of CTL function is lytic granules such as granzymes, which 
are delivered to the target cell with perforin, and function to initiate apoptotic machinery within 
the cell forcing it to undergo programmed cell death.  In addition to their cytotoxic effector 
mechanisms, CD8+ T cells also secrete IFN-γ and TNF, both potent anti-viral cytokines.   
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1.3.2.3 Initiation of the T cell response 
As stated above, DCs within the DLNs that acquired HSV-1 antigens present them to CD8 and 
CD4+ T cells in the context of MHC class I and II, respectively.  Naïve T cells traffic through the 
DLNs and can come into contact with these DCs.  When a T cell that recognizes its cognate 
antigen comes into contact, they require three distinct signals to initiate commitment to effector 
T cell lineage.  The first signal is that of the antigen presented in the context of MHC, which is 
recognized by the T-cell receptor. The second signals are mediated by costimulatory molecules.  
These molecules are only unregulated on a DC when it has received maturation signals, such as 
activation of TLRs to viral associated elements.  In the absence of these interactions such as 
B71.1/1.2:CD28 and CD40:CD154  T cells will be tolerized to the antigen (82,83).  The final and 
third signal are cytokines such as IL-4 or IL-12, which not only allows proper activation of naïve 
T cells but also promotes differentiation into effector T-subset.  As seen in figure 5 IL-12, a 
cytokine produced normally by APCs, promotes the differentiation of a naïve T cell into one that 
is equipped to combat intracellular pathogens such as HSV-1 (84,85). 
When a naïve T cell obtains the proper signals to differentiate into an effector T cell, the 
process of clonal expansion begins.  In most cases, T cells initiate a massive expansion (up to 
50,000 fold increases), acquiring an activated phenotype and exiting the lymphoid organ (86).  
During this stage T cells enter into circulation and travel throughout the body, notably to sites of 
infection, which is the cornea and TG in the case of ocular HSV-1 infection. From initiation of 
clonal expansion, T cells peak in number within 5-7 days.  After this phase, T cells undergo an 
organized process of cell death called contraction where the vast majority of effector cells are 
lost.  The small population that survives is the memory pool; these cells are characterized by 
long term survival and rapid response upon encounter with antigen (87). 
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1.3.3 T cell memory  
1.3.3.1 Memory precursors  
Much work has been expended in understanding how T cell memory is formed and maintained.  
As much more is understood concerning CD8+ T  cell memory, this section will largely discuss 
how CTL memory is formed.  During the effector stage, certain events take place that pave the 
way for memory development. One study found that when effector T cells engage an APC and 
undergo clonal expansion, they divide asymmetrically; they observed that the daughter cell distal 
to the APC retained less CD3,CD8 and LFA-1, but higher levels of the protein PKC-ξ (88).  
Furthermore they found that these distal daughter cells had a phenotype that was similar to that 
of memory, while the proximal cells had an effector cell phenotype.  Another group of studies 
identified memory precursors, effector cells phenotypically distinct from the effector pool that 
tended to survive contraction to go on and form memory.  Memory precursors tended to retain 
expression of IL-7R, which is downregulated on effector expansion), and lacked the expression 
of killer cell lectin-like receptor G1 (KRLG1) seen on short lived effector cells (89-91).   
1.3.3.2 Central and Effector Memory 
Mirroring the phenotypic wrinkles of the effector pool, memory cells also retain certain 
phenotypic differences.   Two major subgroups of memory exist: central memory and effector 
memory.  These two groups have distinguishing characteristics and functionality.  Central 
memory, as the name implies, are largely found within the lymphoid organs.  They tend to 
express CD44, CD127, CD62L, and CCR7, but are capable of expanding rapidly in response to 
antigen (92).  Effector memory cells tend to be found in the periphery, and lack the lymphoid 
organ homing receptors CD62L and CCR7, but also retain high levels of CD44 and CD127.  The 
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most striking differences of effector memory T cells is their ability to rapidly produce IFN-γ and 
TNF-α when compared to central memory (93).  It is thought that effector memory cells exist to 
rapidly respond to their corresponding antigen, playing a delaying action while central memory 
cells rapidly expand into new effector cells to eradicate the pathogen.  The mechanism by how 
effector and central memory form remain a mystery, but certain groups have observed memory 
precursors formed earlier in clonal expansion tend to form central memory, while those forming 
later go on to form effector memory (94,95). 
1.3.3.3 CD4+ T  cell help of CD8+ T  cell memory 
Illustrating the complex interplay in the immune response, CD4+ T  cells have been implicated in 
aiding CD8+ T cell memory formation.  A large number of early studies employing noninfectious 
immunizations observed CD4+ T  cell interaction with DCs via CD40:CD40L were necessary for 
the formation of both CTL effector populations and their subsequent functional long-lived 
memory (96,97). However, in models of acute infectious disease, it became apparent that 
ubiquitous components of pathogens, called PAMPs (pathogen associated molecular patterns) 
could induce DC maturation independent of CD4+ T cells, resulting in a normal CD8+ T cell 
effector response, but a defective CD8+ T cell memory pool.  These findings suggested a 
“programming” model in which signals from CD4+ T  cells during the priming and expansion 
phase programs CD8+ T cells for functional memory (98,99).  Recent studies forward a scenario 
where CD4+ T  cells augment programming of CD8+ T  cells through the production of IL-2 
(100,101).  A second study has identified a role where CD4+ T  cells enhance IL-15 production 
from DCs, which in turn helps form fully functional CD8+ T  cell memory (96,97,102). 
 A smaller body of work suggests a completely different role for CD4 help.  Bevan et al 
observed CD8+ T  cell memory diminished over time when transferred into CD4 deficient hosts.  
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They concluded CD4+ T  cells are helping to maintain memory in non-antigen specific fashion 
(103).  The mechanisms by how CD4+ T  cells effect this maintenance is unclear; It is well 
established that CD8+ T  cell memory does not require regular antigen engagement, but the 
homeostatic maintaining signals via IL-7 and IL-15 (87,104).  So far no evidence has linked 
CD4+ T  cells to the production of these cytokines.  It does appear in light of all these data that 
the requirements for CD4 help in the formation of CD8+ T  cell memory warrants further 
experimental elucidation.   
1.3.4 The immune response and HSV-1 Latency  
1.3.4.1 CD8+ T  cell Immunosurveillance of latently infected neurons 
Strong evidence demonstrates that macrophages and γδ T cells play an integral role in keeping 
viral replication in check within the ganglion while the adaptive immune system is marshaled.  
Studies have also established the critical role for CD8+ T cells in bring viral replication under 
control early within the trigeminal ganglion.  How does the immune response continue as the 
virus achieves latency in the neurons? 
CD8+ T  cells enter into the TG and peak in numbers at 8 days post infection (dpi), 
concurrent with the initial establishment of latency of HSV-1.  In the B6 murine model of 
infection, the majority of the infiltrating CD8+ T  cells (50%) are specific for an 
immunodominant epitope on the glycoprotein B protein (gB498-505) (105,106).  These cells, from 
here on described as gB-CD8, undergo contraction that stabilizes and forms a pool of cells which 
are retained for the life of the animal.  The majority of these memory gB-CD8 maintain an 
activated phenotype by CD69 and granzyme B expression, suggesting that these cells are 
receiving antigenic stimulation within the TG well after viral latency has been established (107).  
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Complementing these observations is the continued expression of a number of inflammatory 
cytokine and chemokine transcripts (108-110). Histological analysis of latent TGs have found 
CD8+ T  cells are found within close apposition of neurons, and their TCR is polarized to the 
neuron cell body, illustrating a scenario where gB-CD8s are regularly recognizing their antigen 
on neurons (106).  As seen in Figure 6, histology of mice infected with a HSV-1 virus that 
express EGFP off the gB promoter reveal neuronal expression of EGFP during viral latency.  
This strongly suggests that neurons latently infected with neurons may be producing viral 
proteins in the absence of detectable infectious virus. 
When TGs are cultured in ex vivo explants, HSV-1 spontaneously reactivates from a 
small number of latently infected neurons.  gB-CD8s are able to protect these neuron cultures 
from reactivation (106,111).  This growing body of data presents a paradigm shift in how we 
think neuron latency is maintained: not only does HSV-1 appear to be reactivating with much 
higher frequency than previously thought, HSV-specific CD8+ T  cells are immunosurveying 
latently infected neurons and actively pushing the virus back into a latent state.   
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 Figure 6 – Neurons within the latently infected ganglia are expressing glycoprotein B 
Histology of whole TGs infected with HSV-1 promoter gB-EFGP.  TGs were harvested during 
HSV-1 latency (35 dpi).  Image courtesy of Brian Sheridan, Ph.D. 
 
A number of subsequent studies have dissected the effector mechanisms by which CD8+ 
T  cells maintain latency.  An important observation found when CD8+ T  cells are added to a 
culture and protection is established, an anti-CD8 antibody can neutralize CD8 function, and 
subsequently neuron reactivation occurs (106).  This instructive observation informs us CD8+ T  
cells, normally a cytotoxic killer, is using non-lytic mechanisms to maintain neuronal latency.  
This protection from neuronal activation is at least partially mediated by IFN-γ (112,113).  More 
recent studies have found lytic granules are capable of protecting the remaining neurons in non-
cytolytic fashion; granzyme B actually cleaves IE viral proteins, thus interfering with viral 
reactivation (114).   
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1.3.4.2 Long term antigen exposure and exhaustion – latent vs. chronic infections 
These studies forward a long-term role for gB-CD8+ T cells, constantly 
immunosurveying latently infected neurons, and when necessary, using their effector 
mechanisms to maintain latency.  This is in stark contrast to what is observed during persistent 
infections with viruses such as LCMV, HCV, and HIV, where long term antigenic stimulation is 
detrimental to CD8+ T  cell functionality (115-117).  In persistent infections induced by LCMV 
clone 13, functional exhaustion of virus-specific memory CD8+ T cells is characterized by the 
serial loss of production of IL-2, TNF, IFN-γ, and granzyme B (115,118).  This CD8+ T cell 
exhaustion appears a result in part from their acquisition of inhibitory receptors (119,120).  
One of the most well studied inhibitory receptors is program death-1 (PD-1).  This 
molecule can be expressed on a large number of cells within the immune system, ranging from T 
cells, NK cells, to activated monocytes (121-123).  Its primary ligand, PD-L1 is widely 
expressed through the body by a large number of immune and parenchymal cells. It is believed 
that PD-1 plays a role in control of effector expansion during normal immune responses.  There 
is evidence that expression of PD-L1 may be induced by inflammatory mediators (124-127).   
Interestingly, mice that are deficient in CD4+ T cells at the time of clone 13 LCMV infection 
exhibit a more profound CD8+ T cell functional exhaustion and never clear the virus 
(115,128,129).    
 CD8+ T  cells isolated from latently infected neurons however remain fully functional 
even months into viral latency (130). A number of potential explanations for this lack of 
exhaustion exist.  It might reflect the fact that replicating virus is rapidly eradicated during acute 
infection, preventing prolonged antigen exposure during the programming of CD8+ T cells.  
Once programming is complete, persistent exposure to low levels of antigen does not appear to 
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have an adverse effect on the virus-specific memory T cell population.  Also, the frequency of 
antigen encounters within the TG appears to be periodic, not constant as seen in classic chronic 
infection models.  Few studies have looked in depth at functional exhaustion in the context of a 
latent infection, and did not observe role of CD4 help of CD8+ T cell memory formation.  One 
such study did observe CD4+ T cell deficiency during the acute phase of murine 
gammaherpesvirus 68 infection renders virus-specific memory CD8+ T cells incapable of 
maintaining viral latency, suggesting that non-helped CD8+ T cells might be susceptible to 
functional exhaustion in the context of a latent viral infection (131,132).   
1.4 THE IMMUNE RESPONSE: IMMUNOPATHOGOLOGY OF OCULAR HSV-1 
INFECTION 
1.4.1 Herpes Stromal Keratitis Pathogenesis  
As stated above, a serious complication of ocular HSV-1 infection is the blinding disease herpes 
stromal keratitis, one of the leading causes of infectious blindness in the United States.  The 
prevalence of the disease within the United States is estimated to be approximately a half million 
cases (8).  In the clinic HSK is defined as either necrotizing keratitis or immune keratitis, which 
is non-necrotizing.  Necrotizing keratitis is considered the more severe of the two diseases, being 
characterized by necrosis, epithelial defects, and heavy leukocytic infiltration into the corneal 
stroma; if left untreated, it can develop on to perforate the cornea.   The second subtype, immune 
keratitis is more frequently seen in the clinic, and is considered a less severe in risk to the cornea.  
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It is defined by heavy leukocytic infiltration, neovascularization, and can persist for weeks.  
Necrosis and epithelial defects do not normally develop in immune keratitis.   
Mouse models of HSK have been developed in efforts to understand the pathogenesis of 
this disease.  Murine HSK has some stark differences with human keratitis.  While HSK in the 
clinic is the result of viral reactivation down to the cornea, HSK in mice develops one week 
following primary infection.  Also, viral replication is often seen in human keratitis, while in 
mice HSK develops following viral clearance from the cornea.  Murine HSK appears to more 
closely resemble immune keratitis, with dense leukocytic infiltrate, neovascularization, and 
persistence of disease over time.  It can also present epithelial defects as disease severity peaks, a 
characteristic of necrotizing keratitis.  Despite these differences, the murine model of HSK has 
shed much light on how disease progresses.  
As stated above, HSK in the mouse begins to develop at 7 dpi.  It is important to note that 
infectious virus is usually not detected in the cornea, suggesting HSK develops in the absence of 
viral replication.  Disease normally peaks in severity between 14-21 dpi, as illustrated in Figure 
7.  This disease is characterized by increasing stromal opacity as well as neovascularization from 
the periphery into the avascular cornea.  HSK lesions in the mouse are characterized by a dense 
infiltration of PMN neutrophils, CD4+ T  cells, dendritic cells, and few CD8+ T  cells (133-135). 
It appears that a large number inflammatory and angiogenic factors work in concert to 
overwhelm the corneal immune privilege. It appears the proximal mediators of stromal damage 
is neutrophil directed matrix metalloprotease 9 (MMP-9), which leads to the corneal scarring and 
damage that lead to blindness (136).  However to understand the pathogenesis of HSK, the 
ultimate mediators of disease must be identified. 
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 Figure 7 - Photographs of HSK development in BALB/C mice 
4 slit lamp photographs depicting the four main severity scores of HSK.  A non-infected normal 
eye has no vessel in growth and is clear.  Mild haziness of the cornea characterizes a severity 
score of 1.  Scores of 2, 3 depict increasing opacity of the corneal stroma, and also increasing 
ingrowh of new blood vessels.  By a disease score of 3, the cornea is very opaque and completely 
neovascularized, and is indicative of blindness.  Image courtesy of Robert Hendricks, Ph.D. 
1.4.2 The role of CD4+ T cells in HSK 
Early studies in athymic nude mice, which lack T cells, found HSK did not develop (137).  HSK 
could be induced in nude mice by an adoptive transfer of T cells, providing strong evidence  
HSK is a T cell driven immunopathology (138). Studies subsequently tested which T cell subset 
contributed more to HSK, and found that CD4+ T  cells were the subset responsible for HSK 
development in mice (139-141).  Furthermore, HSK was established as a TH1 mediated disease.  
TH1 cytokines, notably IL-2 and IFN-γ were identified to be critical in HSK progression; IL-2 
providing chemotactic and survival signals to PMN neutrophils, and IFN-γ upregulating PCAM-
1 on blood endothelial cells, promoting PMN extravasation into the cornea (142,143).  Taken 
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collectively, strong evidence exists that HSK is a TH1 mediated disease, orchestrated by CD4+ T 
cells.  This leads to the next question, how and why are CD4+ T cells mediating such a 
destructive immune response within the cornea? 
A large body of work has attempted to resolve these questions, and the answer remains 
contentious.  These studies have forwarded three models of how CD4+ T cells are initiating 
HSK: molecular mimicry, bystander activation, and HSV-1 specificity.  The model of molecular 
mimicry states autoaggressive CD4+ T cells falsely recognize host antigens that bear similarities 
to the viral protein UL6 are mediating HSK (144-147).  However, these findings are complicated 
by observations that this auto-immune response occurs only in corneal infection with the KOS 
strain of HSV-1, not the RE strain.  Moreover, a study by another group failed to confirm cross-
reactivity between the UL6 protein and corneal proteins, or the capacity of UL6-specific CD4+ T 
cells to induce HSK (148).  Additionally, analysis of the specificity of T cell clones isolated from 
human corneas with HSK has not revealed reactivity to either UL6 or corneal antigens (149).  
These conflicting studies call into to doubt the validity that molecular mimicry is a wide-spread 
mechanism for how CD4+ T cells induce HSK. 
The model of bystander activation induced HSK states large amount of inflammatory 
cytokines produced in the cornea during HSV-1 ocular infection may drive normally non-
aggressive “bystander” T cells into activating their effector functions, creating a “cytokine 
storm” that further drives bystander activation, inducing HSK.  This model is supported by data 
obtained from early studies using mice that are transgenic CD4 TCR specific for ovalbumin 
(ova).  Although the CD4+ T cells of these mice were incapable of recognizing viral antigens, the 
mice developed severe corneal inflammation following HSV-1 infection.  CD4+ T  cells 
expressing the ova-specific TCR were recovered from the HSK lesions, and CD4+ T cell 
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depletion abrogated inflammation (150).  These studies provided proof of principle that HSK-
like disease can develop in the absence of HSV-1 reactive CD4+ T cells.  However, the model 
contained serious flaws that complicate interpretation.  Lacking a HSV-1 specific adaptive 
immune response, virus was never cleared from the corneas, and mice showed high morbidity at 
the time of HSK evaluations.  In fact, when HSV-1 replication was controlled with anti-viral 
drugs, little inflammation developed (151).  Thus, while these models showed the uncontrolled 
viral replication can lead to bystander activation of CD4+ T cells, this is not the case in 
immunocompetent mice that control HSV-1 replication.  While it seems likely that bystander 
activation may play a role in HSK once inflammation is well developed, the evidence strongly 
suggests another force is needed to initiate HSK. 
A view favored by our group and others is that HSV-1 specific CD4+ T cells play a 
requisite role in the induction and progression of HSK.  HSV-1 specific CD4+ T cell clones have 
been isolated from human and mouse (our unpublished observation) corneas at various stages of 
HSK (149).  Perhaps the best evidence for an involvement of HSV-1 specific T cells in HSK 
came from studies where mice were tolerized to HSV-1 antigens.  Injection of HSV-1 into the 
ocular anterior chamber induces a deviant form of immunity referred to as anterior chamber-
associated immune deviation (ACAID) (152).  Preferential inhibition of CD4+ T cell functions such 
as delayed-type hypersensitivity and production of TH1 cytokines characterize ACAID (153).  
Induction of ACAID to HSV-1 antigens at the time of HSV-1 corneal infection protected the 
cornea from HSK (154).  Furthermore, in human patients with active HSK, HSV-1 specific T 
cells have been isolated from corneal buttons, suggesting that viral specificity is important for 
HSK progression (149,155). 
 27 
Realistically, HSK is probably driven by a combination of HSV-1 specific cells and 
bystander activated cells.  As HSK is a chronic disease and also occurs in the absence of live 
virus (in our murine model of HSK), it is rational to hypothesize that HSV-1 specific CD4+ T 
cells initiate HSK in response to HSV-1 antigens, after which the “cytokine storm” leads to 
bystander activation, which contributes to the chronicity of the disease.   Further experimentation 
is needed to definitively identify the role of HSV-1 specific CD4+ T cells in the initiation of 
HSK. 
1.4.3 The role of APCs in HSK 
In previous sections we have detailed how important dendritic cells and other APCs are in 
generating the protective adaptive immune response to HSV-1.  Given the immune component of 
HSK, the question arises: do APCs also play a role in the immunopathogenesis of HSK?  Within 
the cornea there are a small number of APCs present within the corneal epithelium basement 
membrane.  The limbal regions of the cornea and the conjunctiva are densely populated by 
dendritic cells, thought to be Langerhans cells (156).  Studies have observed that these peripheral 
DCs move into the central cornea very rapidly upon corneal insult, and presumably directly or 
indirectly transport antigens for presentation for the immune response.  Studies looking at the 
role of APCs in ocular HSV-1 infection suggest that APCs may be playing a pathogenic role in 
HSK as well. 
Studies from several laboratories have established an important role for corneal DCs in 
HSK.  When the surface of one mouse eye is exposed to ultra violet light, LCs are depleted from 
the epithelium  When one eye is UV irradiated and the mouse is bilaterally corneally infected, a 
role for DCs is observed not only in the inductive phase of the T cell response in lymphoid 
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organs, but also in the effector phase of the response within the infected cornea (157).  The latter 
conclusion was based on the observation that HSK developed normally in the eye with DCs, but 
failed to develop in the LC-depleted cornea.  This raises an interesting concept that DCs within 
the cornea are playing a direct role in destroying the immune privilege that is combating the 
initiation of HSK.  Another study used two different strains of HSV-1 to study APC roles in 
HSK (140).  The KOS strain of HSV-1 gives rise to a low incidence of HSK, which tends to be 
mild in severity when compared to the HSV-1 RE, which gives rise to severe HSK in high 
incidences.  It was identified KOS was a poor inducer for the peripheral migration of DCs into 
the central cornea following initial infection; when this migration was induced, HSK that 
developed following KOS infection was similar to that of RE.    
 Subsequent studies observed a large secondary influx of DCs into corneas that went on to 
develop HSK.  Furthermore they identified that local blockade of the costimulatory molecule 
B7.1 within the cornea hindered HSK development (158).  Other studies found local 
OX40:OX40L and CD40:CD40L costimulatory interactions were dispensable to HSK 
development (159,160).  Regardless, this strongly suggests that local antigen presentation and 
costimulation by APCS is necessary for the initiation of HSK.  
Other studies have looked at factors normally produced by APCs and how they influence 
HSK development.  The IL-12 cytokine family, consisting of the heterodimers IL-12, IL-23, IL-
27, and IL-35, has received attention due to its diverse and complex functions in immunity. IL-
12 consists of a p40 and a p35 subunit(161) and stimulates the differentiation and activation of 
naïve CD4+ T cells toward a TH1 phenotype, promoting IFN-γ production (162). The role of IL-
12 in disease has been confounded by the discovery of IL-23, which consists of the same p40 
subunit coupled to a unique p19 subunit (163). IL-23 promotes both proliferation of 
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effector/memory TH1 cells and also the maintenance of TH17 cells whose signature cytokine is 
IL-17 (164). Interestingly, homodimerization of p40 yields a unique molecule capable of anti-
inflammatory function through blockade of the IL-12Rβ1 (165,166) but also of pro-
inflammatory function as a chemoattractant for DC and macrophages (167,168).  Muddying the 
waters further, p35 can also interact with a second binding partner, Esptein-Barr virus-induced 
gene-3 (EBI3), forming the inhibitory cytokine IL-35 (169,170).  IL-35 promotes the 
proliferation of and IL-10 production by CD4+CD25+ FoxP3+ natural Tregs, inhibits proliferation 
of CD4+ CD25- effector cells, and inhibits differentiation of TH17 cells.  Thus, IL-35 is 
considered to be an anti-inflammatory cytokine.  The final member of the family, IL-27 consists 
of EBI3 and p28 (IL-30) and enhances TH1 polarization of naïve CD4+ T  cells (171). 
The role of the primary TH1 driving cytokine IL-12 in HSK has been investigated 
previously with conflicting results. IL-12p40 mRNA and protein increases in response to HSV-1 
corneal infection (172) and the protein is released by inflammatory cells rather than by infected 
epithelial cells (173). However, during the period of HSK development (7-22 dpi) IL-12p40 
mRNA levels decrease in the cornea, and to our knowledge IL-12p70 protein levels have not 
been measured. Transgenic expression of IL-12p35/p40 fusion protein under the glial fibrillary 
acidic protein promoter (GFAP, expressed by nervous tissue) following ocular infection with the 
highly neurovirulent HSV-1 strain McKrae resulted in reduced viral titers in eyes and trigeminal 
ganglia and increased survival in mice (174). However, another study in which the corneas of IL-
12p35-/- and IL-12p40-/- mice were infected with HSV-1 McKrae found no difference in corneal 
viral load but reduced HSK severity among IL-12p35-/- mice and no HSK among IL-12p40-/- 
mice, that had survived lethal infection at 28 dpi (175). The use of the highly neurovirulent 
McKrae strain of HSV-1, coupled with the study of HSK at a single time point only in animals 
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that had survived lethal infection limits the interpretation of  these studies and their translation to 
human infection.   
IL-23 has also recently been studied in the context of HSK.  Mice deficient in p19 
developed more severe lesions with higher incidence than their WT counterparts (176).  This 
study concluded that the lack of IL-23 resulted in a drastically increased IL-12 driven TH1 CD4+ 
T cell response, though no direct evidence implicating IL-12 in the enhanced HSK was provided.  
When these studies are observed collectively, it becomes apparent that the exact role of 
DCs early in HSV-1 infection, and how this alters immune privilege to HSK need more 
elucidation.  The studies looking at the IL-12 cytokine family also point to a potential role of this 
classically APC produced cytokine in ocular disease, and also requires further experimentation to 
clarify how it contributes to HSK. 
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2.0  SPECIFIC AIMS  
Previously published studies, when taken collectively, suggest that CD4+ T cells play dual roles 
in HSV-1 ocular infection, not only providing key signals to aid the formation of CD8+ T  cell 
memory that will remain functional within the ganglia, but also a pathogenic role in initiating 
HSK.  We also see that dendritic cells that both reside and infiltrate into the cornea can have dual 
roles in directing the immune responses that control HSV-1 as well as playing a part in the 
immunopathology of HSK.  To further study these diametrically opposed actions of CD4+ T cells 
and dendritic cells the aims of this thesis were as follows: 
 
Determine the role CD4+ T cells in the generation and maintenance of virus specific CD8+ 
T cells during HSV-1 infection and latency 
Hypothesis: CD4+ T cells are necessary for optimal generation of CD8+ T cell memory, 
but are dispensable for maintaining the memory pool.  Defective memory residing in the latently 
infected TG will be rescued by periodic encounter with antigen, while memory pools residing in 
non-infected tissue will remain compromised.  
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Identify the contributions of HSV-1 specific and bystander activated CD4+ T cells in the 
development of HSK 
Hypothesis: Following HSV-1 infection, HSK is triggered by HSV-1 specific CD4+ T 
cells, while progression of disease requires HSV-1 specific CD4+ T cells with a supplemental 
contribution from bystander activated cells.  
 
Define the role of IL-12p35 and IL-12p40 in the progression of herpes stromal keratitis 
 Hypothesis:  IL-12p70 is necessary for both the initiation and progression of herpes 
stromal keratitis.  IL-12p40 homodimer and IL-23 both are not necessary for the inflammation 
that drives herpes stromal keratitis. 
 
Identify the role local CD11c+ dendritic cells in the innate driven control of HSV-1 ocular 
infection  
 Hypothesis: Local or early responding DCs within the cornea provide in situ signals that 
both direct the innate immune response to areas of viral infection within the cornea as well as 
initiate the adaptive immune response to HSV-1. 
  
 33 
3.0  MATERIALS AND METHODS  
3.1 REAGENTS  
gB498-505 (SSIEFARL) peptide was purchased from Invitrogen.  Phycoerythrin (PE)-conjugated 
H-2Kb tetramers complexed with the gB498-505 peptide were kindly provided by the NIAID 
Tetramer Core Facility (Emory University Vaccine Center).  Fluorochrome labeled antibodies 
against CD3 (clone 17A-2), CD4 (RM4-5), CD11a (2D7), CD25 (PC61), CD43 (1B11), CD45 
(30-F11), CD49b (DX-5), VLA-4 (R1-2), CD69 (H1.2F3), CD107α (1d45), IFN-γ (XMG1.2), 
TNF (MP6-XT22), V-beta 8.1/8.2 (MR5-2), and I-A/I-E (M5/114.15.2) were purchased from 
BD Pharmingen (San Diego, CA).  Fluorochrome labeled antibodies against CD8α (53-6.7), 
CD11b (M1/70), CD11c (N418), GR-1 (RB6-8CA), FoxP3 (FJK-1GS), and PDCA-1 (ebio927) 
were purchased from eBiosciences (San Diego, CA).   Fluorochrome labeled antibodies against 
PD-1 (RMP1-30) and VLA-4 (R1-2) were purchased from Biolegend (San Diego, CA).  
Fluorochrome labeled α-langerin antibody (929F3.01) was purchased from Dendritics (Lyon, 
France).  The appropriate isotype control antibodies were purchased their respective vendors. 
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3.2 MICE  
3.2.1 Mice strains used in these studies 
Six- to 8-week-old female wild type (WT) C57BL/6, BALB/cJ, IL-12p35-/- BALB/c, and IL-
12p40-/- BALB/c and CD11c-DTR (C.FVB-Tg(Itgax-DTR/EGFP)57Lan/J) mice were purchased 
from Jackson laboratories (Bar Harbor, ME).   The IL-12p35-/- and IL-12p40-/-mice were bred 
through 4 generations to produce IL-12p35-/-p40-/-double knockout mice. IL-12p35 and IL-12p40 
genes were individually genotyped to confirm knockout status using the following primers: IL-
12p35 (forward 5'-CTGAATGAACTGCAGGACGA-3', reverse . 5'-
ATACTTTCTCGGCAGGAGCA -3', expected size 172 base pairs) and IL-12p40 (forward 5'- 
CTTGGGTGGAGAGGCTAT TC -3', reverse 5'- AGGTGAGATGACAGGAGATC -3', 
expected size 280 base pairs). All experimental animal procedures were reviewed and approved 
by the University of Pittsburgh Institutional Animal Care and Use Committee and adhered to the 
ARVO Statement for the Use of Animals in Ophthalmic and Vision Research. 
 
3.2.2 Murine Bone Marrow Chimera Generation 
ChimeraCD11c-DTR mice required the generation of bone marrow chimeras for these studies, as 
intact CD11c-DTR mice can succumb to repeat treatments of diphtheria toxin.  Briefly, BALB/cJ 
hosts underwent two treatments of 500 rads in an animal γ-irradiator, four hours apart.  At the 
end of the irradiation regimen, 2.5x105 bone marrow cells from a CD11c-DTR donor were 
transferred intravenously (iv).  Mice were housed under immunocompromised mouse conditions 
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and treated regularly with 2mg/mL neomycin from Sigma (St. Louis, MO) in their drinking 
water.  Mice were considered fully reconstituted and ready for experimental use after 6 weeks. 
3.2.3 In vivo antibody treatment  
Mice were treated with an i.p injection of 0.15mg of rat anti-mouse CD4 antibody clone GK1.5 
(BioXcell, Weston, FL) for in vivo depletion of CD4+ T  cells.  For depletions prior to infection, 
injections were given 2 days before infection, followed by +1, +3, +8, +15, +22, +29, +36, +43, and 
+50 dpi.  For depletions during contraction, treatments were given at +8, +15, +22, and +29 dpi. 
For PDL1 blockade, mice were treated with 0.2mg of rat anti-mouse PDL1 antibody clone 
10F.9G2 (BioXcell) every 3 days for 2 weeks prior to desired observation point.   
3.2.4 In vivo Diphtheria toxin treatment 
Diphtheria toxin (DT) purchased from Sigma Laboratories was prepared in a sterile solution of 
PBS at a concentration of 1mg/mL.  For local treatment in the cornea, 50ng of DT in a 10uL 
volume was subconjunctivally injected.  For systemic treatment, mice were injected i.p. with 
150ng DT.  For continuous treatment, injections were repeated every three days, with a lower 
dose (20ng for local treatment, and 100ng for systemic treatment). 
3.2.5 Herpes Stromal Keratitis Scoring  
Mice were monitored for HSK on alternate days between 7 and 21 days post-infection (dpi) by 
slit lamp examination. A standard scale ranging from 1 – 4 based on corneal opacity was used: 1+ 
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mild corneal haze, 2+ moderate opacity, 3+ complete opacity, 4+ corneal perforation. Disease 
incidence was defined as HSK score greater or equal to 2 by 15 dpi. The extent of 
neovascularization and peri-ocular skin disease was also recorded.   
 
 
3.3 VIRUS PROTOCOLS  
3.3.1 Virus preparation and ocular HSV-1 infection 
HSV-1 strain RE was grown in Vero cells, and intact virions were isolated on Optiprep gradients 
according to manufacturer’s instructions (Accurate Chemical and Scientific Corp, Westbury, 
NY).  Viral titer described as plaque forming units per mL (pfu/ML) was established by standard 
plaque assay infections of vero cell monolayers.  For ocular HSV-1 infection, mice were 
anesthetized by intraperitoneal (i.p.) injection of 2.0 mg ketamine hydrochloride and 0.04 mg of 
xylazine (Phoenix Scientific) in 0.2 mL of Hanks balanced salt solution (Biowhittaker).  The 
abraded central corneas of anesthetized mice were infected by topical application of 3μL of 
RPMI (Biowhittaker) containing 1 x 105 plaque-forming units (PFU) of HSV-1.  All animal 
experiments were conducted in accordance with guidelines established by the University of 
Pittsburgh Institutional Animal Care and Use Committee. 
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3.3.2 Generation of 10 hour HSV-1 infected target lysates 
HSV-1 antigens were extracted from Vero cells (3.5 x 106/mL) at 10 hours after HSV-1 RE 
infection (multiplicity of infection of 4). Confluent flasks of Vero cells were infected at an MOI 
of 4 for one hour, washed twice with Vero growth media (DMEM supplemented with: 10% FCS, 
1% HEPES (Cambrex Bioscience, Charles City, IL), 0.1 mM nonessential amino acids 
(Invitrogen, Carlsbrad, CA), 1mM sodium pyruvate (Invitrogen), L-glutamine (2mM) 100U/ml 
penicillin and 100ug/ml streptomycin) and then incubated for 9 hours to generate the 10 hour 
lysates.  To extract viral antigens, vero cells were subject to two 2 min homogenization cycles 
using the Retsch MM 300 Mixer Mill homogenizer, followed by three freeze/thaw cycles.  The 
cell lysates was then UV inactivated for 10 minutes at 5cm. 
3.4 PHENOTYPIC ANALYSIS OF CELLS 
 
3.4.1 Tissue Preparation for Flow Cytometry 
At indicated time post infection, mice were sedated and euthanized by cardiac perfusion with 
sterile PBS.  Prior to perfusion draining lymph nodes (DLN), spleens, and corneas were 
harvested.  DLN, Spleens, and Lungs were minced, and then incubated with 500uL (spleen, 
DLN), or 1mL (lungs) of DMEM (Biowhittaker, Walkersville, MD) containing 10% FCS 
(Atlanta Biologicals, Atlanta, GA) and 400U/mL collagenase type I (Sigma) for 1 hr at 37°C. 
Trigeminal Ganglions (TG) were digested in 100μL (TG) of collagenase or 1 hour at 37°C.  
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Corneas were treated with PBS 2mM EDTA for 15 minutes, and then the pigment epithelium, 
conjunctiva, and epithelium were dissected away from the cornea stroma.  The cornea was cut 
into quarters, and incubated in 100ul of collagenase at a concentration of 800U/mL for 1 hour.  
Tissues were then dispersed into single cell suspensions (TGs and corneas via trituration with a 
micropipette) by and if necessary, treated with red blood cell lysis buffer prior to staining with 
the designated antibodies.  Data were collected on a FACSAria cytometer and analyzed by 
FACSDiva software (BD Biosciences). 
 
3.4.2  Phenotypic analysis 
For all phenotypic analyses, cells were stained for CD45 to permit gating exclusively on bone 
marrow-derived cells.  For analysis of CD8 and CD4+ T  cell populations and their phenotype, 
cells were stained with anti-CD8α and anti-CD4. For analysis of HSV-1 specific CD8+ T cells 
(gB-CD8), cells were additionally co-stained with anti-CD8α and gB498-505 H-2Kb tetramers. 
3.4.3 Fluorescently assisted cell sorting 
At indicated time points, lungs and draining lymph nodes were dispersed into single cell 
suspension and stained with anti-CD8 and gB498-505 H-2Kb tetramers. Cells were sorted at high 
purity (purity-32) for CD8+ gB tetramer+ cells on a FACSAria cytometer (BD Biosciences). 
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3.5 T CELL FUNCTIONALITY 
3.5.1 CD8+ T  cell stimulation for Intracellular cytokine staining and lytic granule 
exocytosis 
Dispersed TG cells or post-gB tetramer sorted cells were stimulated directly with either 10-6 M 
(optimal) or 10-11 M (sub-optimal) gB498-505 peptide pulsed B6WT350 fibroblast targets in the 
presence of FITC-conjugated anti-CD107a mAb and Golgi-plug (BD Biosciences) for 6 hr at 
37°C/5% CO2.  The optimal and suboptimal peptide concentrations are based on previous studies 
(130). Following stimulation, cells were stained for surface expression of CD8α, followed by 
intracellular staining for IFN-γ and TNF-α after permeablization and fixation via 
Cytofix/Cytoperm (BD Biosciences). CD107a capture on the cell surface during stimulation 
provides sensitive detection of lytic granule exocytosis as previously described (177,178) 
3.5.2 CD4+ T  cell stimulation 
At indicated time points, DLNs were excised and dispersed into a single cell suspension.  CD4+ 
T  cells were isolated via negative selection using the CD4+ T  cell isolation MACS bead kit 
(Miltenyi Biotech, San Diego, CA).  T cells were then incubated at a 1:4 ratio with T cell 
depleted splenocytes that had been loaded with HSV-1 10 hour lysate overnight.  The cells were 
cultured at 37°C for 72 hours, after which supernatant was collected for ELISA.  Alternatively, 
for the last 12 hours of culture, golgi plug was added to arrest secretion of cytokines, followed by 
intracellular staining as described above. 
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3.5.3 Tetramer release assay  
This assay was performed as described (179).  Briefly, single-cell TG suspensions were stained 
with gB498-505 tetramer for one hour at 37°C,  the cells were then washed and then incubated with 
anti-H-2Db/Kb antibody to halt tetramer re-binding (28-8-6; BD Pharm) at 37°C for the 
designated times.  Cells were then stained with anti-CD8α and anti-CD45 mAb, and analyzed via 
flow cytometry to observe loss of tetramer over time.  Data expressed as CD8+ tetramer+ cells as 
a percentage mean fluorescence intensity (MFI)± SEM of the maximum binding observed at 
time zero. (n=10 mice/group) 
 
3.6 DETECTION OF SOLUBLE FACTORS 
3.6.1 ELISA for secreted IFN-γ  
Immulon Microtiter plates (Thermo Labsystems) were coated overnight with primary anti-IFN-γ 
capture antibody (R4-6A2, ATCC). The plates were washed and blocked with 1% BSA in PBS.  
The supernatant fluids and standards were added and incubated at room temperature for 2 h.  The 
plates were washed again, secondary biotinylated anti-cytokine detection Ab (polyclonal goat 
anti-mouse IFN-γ, R&D Systems) was added and incubated at room temperature for 1 h.  The 
plates were then washed and developed with strepavidin-horseradish peroxidase (BD 
Pharmingen) and its substrate ((3,3’ 5,5’-Tetramethylbenzidine Base, GIBCO BRL).  Using 
standards as guides, the development was halted by the addition of 1N sulfuric acid. The colored 
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reaction product was measured with an enzyme immunoassay plate reader at 450 nm.  The 
amount of cytokine in each supernatant was extrapolated from a standard curve.  The detection 
sensitivity was 5.6 pg/ml for IFN-γ. 
 
3.6.2 Detection of chemokine and cytokine production in vivo by bead assay 
Individual corneas were excised at 17 dpi, quartered in sterile PBS, and pieces were transferred 
to tubes containing 300 μl PBS + complete protease inhibitor (Complex Mini Protease Inhibitor, 
Roche Applied Science, Indianapolis, IN) and sonicated (Fisher Model 100 Sonic Dismembrator, 
Fisher Scientific) 4 times for 15 seconds each.  The sonicator tip was rinsed with 75 μl PBS + 
protease inhibitor, yielding a final volume of 600 μl/sample. To remove cellular debris, samples 
were microcentrifuged twice. 23-plex mouse cytokine/chemokine Bio-Plex assay (BioRad) was 
performed according to manufacturer’s instructions. 
3.7 DETECTION OF VIRAL LOAD IN VIVO 
3.7.1 Detection of infectious virus on corneas 
The corneal surfaces of mice were swabbed with sterile Weck-Cel surgical spears (Medtronic 
Solan, Jacksonville, FA) on days +2, +4, +6, +8 after HSV-1 infection, spears were placed in 0.5 
ml RPMI, and frozen at -80° C until assayed.  Samples were added to confluent Vero cells, 
incubated for 1 hour at 37° C, and overlayed with 0.5% methylcellulose.  The cultures were 
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incubated for 72 hours, fixed with formalin, stained with crystal violet and viral cytopathic effect 
was detected with the aid of a dissecting microscope. 
3.7.2 Quantitative real-time PCR for single viral genome copies  
Total DNA was isolated from single-cell TG suspensions using DNeasy columns according to 
manufacturer’s instructions (Qiagen, Valencia, CA). DNA was quantified by spectrophotometry 
and diluted to 1 ng/μl in nuclease-free dH2O. 25 ng DNA or water control was mixed in 
duplicate with 25 μl mixture of TaqMan Universal PCR Master Mix (Roche) and an HSV-1 
glycoprotein H (gH)-specific primer-probe set, custom designed and synthesized by ABI Assays-
by-Design service. Samples (50μl/well) were assayed in 96-well plates with an ABI Prism 7700 
sequence detector. ABI Primer Express v1.5a software default settings were used for instrument 
control and data analysis. The gH sequences were: forward primer (5’- 
CGACCACCAGAAAACCCTCTTT-3’), reverse primer 
(5’ACGCTCTCGTCTAGATCAAAGC-3’), and probe [5’-(FAM)TCCGGACCATTTTC(NFQ)-
3’]. 
3.8 WHOLE MOUNT FLUOROSECENT MICROSCOPY 
Whole corneas were excised from mice.  The pigment epithelium was dissected away carefully, 
with special attention given to avoiding damage to the epithelium and conjunctiva.  Corneas 
were cut in a cloverleaf fashion, washed in PBS 4% FBS, before stained with indicated 
antibodies in 4% FBS overnight at 4°C.  Corneas were washed with PBS 4%FBS, fixed in 1% 
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paraformaldehyde (PFA) for 2 hours, washed once more in PBS 4% FBS,  and mounted.  For 
intracellular staining, following the primary antibody, corneas were washed with PBS 4% FBS, 
fixed and permeabilized in Cytofix/Cytoperm (BD), washed in Perm/wash (BD), and stained 
with intracellular antibodies overnight.  Corneas were then washed in Perm/wash the following 
day and mounted.  Images were acquired on an Olympus Fluoview 1000X confocal microscope 
with a 1.4NA 60X oil objective.  Images were acquired by sequential scanning to avoid 
fluorescence crossover, and Z stacks were acquired at Nyquist sampling frequency through the 
tissue. All image reconstructions were made using Metamorph. 
3.9 STATISTICAL ANALYSIS 
All statistical analyses were computed with GraphPad Prism software using unpaired t-tests. P 
values <0.05 were considered statistically significant. 
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4.0  THE ROLE OF CD4+ T  CELLS IN THE GENERATION OF HSV-CD8+ T  CELLS 
CD4+ T cells have long been implicated a critical role in the formation of long-lived functional 
CD8+ T  cell memory.  The requirements for CD8+ T cell memory in context of viral infection 
diverge from acute models of infection, as latent virus can influence functional properties of 
CD8 memory T cells.  Here we examined the role of CD4+ T cell help in the generation of HSV-
1 specific CD8+ T  cells, and how the unique properties of viral latency impact this process. 
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4.1 CD4+ T  CELL ABLATION INFLUENCES HSV-1 LATENCY  
 
Figure 8 – Anti-CD4 antibody effectively ablates CD4+ T cells from mice 
Representative dot plots depicting CD8+ and CD4+ T cell populations within the infected ganglion and 
spleen of mice.  At indicated time points dispersed ganglion and spleens were stained with antibodies and 
analyzed via flow cytometry.  Panels A and B depict Tx starting at -2dpi.  Panels C, D represent Tx started 
at 8 dpi.  Flow plots were gated on CD45+ cells. 
 
Initial studies tested the effect of CD4+ T cell ablation starting before HSV-1 corneal infection 
on the clearance of virus from the cornea, the establishment of viral latency in the trigeminal 
ganglion (TG), and on the maintenance of latency. Our studies employed an antibody treatment 
protocol that effectively ablated CD4+ T cells from mice beginning 2 days before HSV-1 corneal 
infection and continuing through 60 dpi (Figure 8).  Here we show that depletion of CD4+ T cells 
through 8 dpi did not influence the clearance of HSV-1 from the cornea (Fig. 9A), the kinetics of 
latency establishment within the TG (not shown), or the load of latent viral genome at 8 dpi (Fig. 
9B).  
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Figure 9 - CD4+ T cell ablation influences the maintenance of HSV-1 latency 
B6 mice that received HSV-1 corneal infections were continuously depleted of CD4+ T cells beginning 2 
days before (A-C) or 8 days after (D) infection. A) At indicated days post infection (dpi), eyes were swabbed with a 
sterile surgical spear and assayed for live virus by standard plaque assay.  The data are presented as the mean ± SEM 
viral plaque forming units (pfu) per cornea of non-depleted (helped) mice and those continuously CD4-depleted 
starting at -2 dpi (non-helped).  B-D) At the indicated dpi, DNA was extracted from trigeminal ganglia (TG) of and 
the number of copies of HSV-1 genome harbored in each TG was determined by quantitative real time PCR for the 
gH gene. Data from individual TG are presented (B&C) viral genomes /TG of helped and non-helped mice. D)  
Viral genomes /TG of non-depleted (helped) mice and those CD4-depleted starting 8 dpi (CD4-depleted > 8 dpi). ** 
p<0.01, * p<0.05), n=5-23 mice per group as indicated in scatter plots) 
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However, the CD4+ T cell ablated mice failed to maintain the virus in a latent state between 8 
and 35 dpi as indicated by a significant increase in the viral genome copy number in the TG (Fig. 
9C).  The latent viral load did return to normal levels by 56 dpi in CD4+ T cell ablated mice.  The 
failure of CD4+ T cell ablated mice to control the early stages of HSV-1 latency did not reflect a 
direct requirement for CD4+ T cells in control of viral latency because initiating CD4-depletion 
at 8 dpi did not result in a similar increase in the latent viral load (Fig. 9D).   
4.2 CD4+ T CELL HELP DOES NOT INFLUENCE THE SIZE OF THE HSV-
SPECIFIC CD8+ T  CELL EFFECTOR OR MEMORY POOL 
We previously demonstrated that diminished function of memory HSV-specific CD8+ T cells 
within latently infected TG was associated with failure to maintain latency as indicated by an 
increase in viral genome copy number (29,180).  Therefore, we hypothesized that the absence of 
CD4+ T help during the first 8 days after HSV-1 infection may have resulted in an HSV-specific 
CD8+ effector and/or memory T cell population within the TG that was incapable of maintaining 
HSV-1 latency.  We used an HSV-1 corneal infection model in C57BL/6 (B6) mice in which 
tetramers containing an immunodominant glycoprotein B (gB498-505) epitope were used to 
identify and quantify a majority of HSV-specific CD8+ T cells (here referred to as gB-CD8).   
The number of CD4+ T cell-helped (helped) and CD4+ T cell non-helped (non-helped) 
gB-CD8 peaked at similar levels in the draining lymph nodes (DLN, data not shown) and the 
infected TG (Fig. 10) at 8 dpi.  In the infected TG, the non-helped gB-CD8 underwent a more 
rapid contraction between 8 and 14 dpi (Fig. 10A), but ultimately established a stable and 
numerically normal memory population (Fig. 10A).  CD4+ T cell ablation starting after the peak 
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of the effector response (8 dpi) resulted in accelerated contraction similar to that seen when 
CD4+ T cells were ablated from the time of infection, suggesting a direct role for CD4+ T cells in 
gB-CD8+ T  cell contraction (Fig. 10B).   
 
Figure 10 – CD4+ T cell help does not influence the size of the gB-CD8+ T cell effector or 
memory population. 
B6 mice that received HSV-1 corneal infections were continuously depleted of CD4+ T cells beginning 2 
days before (A) or 8 days after (B) infection.  At indicated days post infection (dpi), TG were excised and HSV-1 
gB-specific CD8+ T cells (gB-CD8) were quantified by simultaneous staining with anti-CD8  mAb and tetramers 
containing the immunodominant HSV-1 gB498–505 epitope (gB498–505 H2-Kb).  A) Mean ± SEM of the absolute 
number of gB-CD8 per TG in non-depleted (helped) and continuously CD4-depleted starting -2 dpi (non-helped) 
mice.  B) Mean ± SEM of the absolute number of gB-CD8 per TG in non-depleted (helped) and continuously CD4-
depleted starting +8 dpi (CD4-depleted > 8 dpi) mice.  (*** p<0.001, * p<0.05) (n=10-15 mice/group) 
4.3 NON-HELPED GB-CD8 EXHIBIT FUNCTIONAL ALTERATIONS UPON 
INFILTRATING THE INFECTED TG.   
In this study we quantified four separate populations of gB-CD8.  As we previously reported 
(130), one population of low functional avidity gB-CD8 produces effector cytokines only in 
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response to an optimal epitope density (1x10-6M gB498-505 peptide loaded fibroblasts); while a 
second high functional avidity population responds to both optimal and suboptimal (1x10-11M 
gB498-505 peptide loaded fibroblasts) epitope densities. Both the high and low functional avidity 
gB-CD8 populations contain subpopulations that express different functional programs: all 
responding gB-Cd8 produce IFN-γ and release lytic granules (IFN-γ/LG) when stimulated, but a 
subpopulation here referred to as polyfunctional also produces TNF-α (IFN-γ/TNF/LG).  No gB-
CD8 were single producers of TNF-α.  These four subpopulations are illustrated in Figure 3B.   
 
We sorted for gB-CD8 in the DLN at 8 dpi to test their functionality (Fig. 11A).  Within 
the DLN, approximately 75 % of both helped and non-helped gB-CD8 responded to optimal gB 
peptide stimulation, and of these approximately 50% showed high functional avidity by 
responding to a suboptimal gB peptide dose (Fig. 11C).  In the TG at 8 dpi, the mean frequency 
of helped gB-CD8+ T hat responded to optimal gB peptide stimulation (67%) was not 
significantly different from their counterparts in the DLN (Fig. 11C).  The frequency of non-
helped gB-CD8 in the TG at 8 dpi that responded to optimal gB peptide stimulation (55%) was 
significantly reduced relative to their counterparts in the DLN (p<0.05) and to the helped gB-
CD8 in the TG (p<0.05).  The frequencies of high functional avidity helped and non-helped gB-
CD8 in the TG at 8 dpi were not significantly different from each other or from their 
counterparts in the DLN (Fig. 11C).   
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 Figure 11 - Non-helped gB-CD8 exhibit functional alterations upon infiltrating the infected TG 
B6 mice that received HSV-1 corneal infections were not depleted or continuously depleted of CD4+ T 
cells beginning 2 days before infection.  A) DLN were excised at 8 DPI, dispersed into single cell suspensions, and 
stained simultaneously with CD8α mAb and gB498-505 tetramer. Tetramer positive CD8+ T cells were sorted via 
FACS with a purity of greater than 90% as illustrated in representative dot plots.  B-D) Sorted DLN cells or 
dispersed TG cells were stimulated for 6 hours with the B6WT350 fibroblast cell line loaded with gB498-505 peptide 
at optimal (1x10-6M) or sub-optimal (1x10-11M) density, in the presence of the Golgi transport inhibitor brefelden-A 
and FITC-conjugated anti-CD107a antibody, followed by intracellular staining for cytokines IFN-γ and TNFα.  B) 
Data are representative flow plots depicting background activation from tetramer binding, as well as IFN-γ and 
TNF-α production and lytic granule (LG) release (CD107a+) following optimal and suboptimal gB peptide 
stimulation.  C&D) Bars represent mean ± SEM total responder cells (IFN-γ/LG) or polyfunctional responder (IFN-
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γ/LG/TNF) cells from both the DLN and TG at 8 DPI.  The total bar represents response to optimal antigen, while 
the bar in bar graph represents response to sub-optimal antigen. (**p<0.01 * p<0.05) (n=8-10 mice/group). 
 
The most dramatic difference between the gB-CD8 effector cells in the DLN and TG at 8 
dpi was in the low frequency of polyfunctional (IFN-γ/LG/TNF) cells in the TG (Fig. 11D).  
While both the helped and non-helped gB-CD8 in the TG showed a marked reduction in the 
frequency of polyfunctional cells in response to optimal gB peptide stimulation relative to their 
counterparts in the DLN, high functional avidity polyfunctional cells were nearly undetectable in 
the non-helped gB-CD8 in the TG.  
4.4 EARLY CD4+ T CELL HELP IS REQUIRED TO AVERT GB-CD8 
FUNCTIONAL COMPROMISE. 
The frequency of helped gB-CD8 in the TG that responded to an optimal gB peptide stimulation 
remained quite constant from 8 through 56 dpi (Fig. 12A).  Interestingly, the frequency of those 
cells that exhibited a high functional avidity by responding to a suboptimal gB peptide dose 
increased dramatically over the same period (Fig. 12A).  In contrast, the non-helped gB-CD8 
showed a sharp decline in functionality from 8 dpi to 14 dpi, when only 14% exhibited a high 
functional avidity.  From 14-35 dpi the frequency of non-helped gB-CD8+ T hat responded to an 
optimal dose of gB peptide declined further, but the frequency of high functional avidity cells 
increased.  The frequency of both populations remained significantly reduced (p<0.05) relative to 
the helped gB-CD8 at 35 dpi.  By 56 dpi the non-helped and the helped gB-CD8 showed the 
same frequency of cells capable of responding to an optimal and suboptimal dose of gB peptide.   
 52 
 Figure 12 - Early CD4+ T cell help is required to avert gB-CD8 functional compromise. 
B6 mice that received HSV-1 corneal infections were not depleted or continuously depleted of CD4+ T 
cells beginning 2 days before infection (non-helped, A&B), or beginning at 8 dpi (C).  At the indicated dpi dispersed 
TG cells were stimulated with an optimal or sub-optimal dose of gB peptide and IFN-γ and TNFα production and 
lytic granule (LG) release were quantified as in Fig. 2.  Data are presented as A) mean % ± SEM of gB-tetramer+ 
CD8+ T cells (gB-CD8) from CD4-depleted and non-depleted mice that responded (IFN-γ/LG) to optimal or 
suboptimal gB peptide stimulation, B) mean % ± SEM of polyfunctional (IFN-γ/LG/TNF) gB-CD8 in response to 
optimal or suboptimal gB peptide stimulation. C) mean % ± SEM of total (IFN-γ/LG) or polyfunctional (IFN-
γ/LG/TNF) gB-CD8 in response to optimal or suboptimal gB peptide stimulation at 35 dpi.  (*** p<0.001, **p<0.01 
* p<0.05) (n=8-10 mice/group). 
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It is noteworthy that in addition to an increased frequency of high functional avidity cells 
within the overall gB-CD8 responding population in the TG from 8-56 dpi (IFN-γ/LG, Fig. 
12A), the helped gB-CD8 also exhibited a gradual increase in the polyfunctional (IFN-
γ/LG/TNF) subpopulation (Fig. 12B), and most of these cells exhibited high functional avidity 
by 56 dpi.  Thus, in the helped gB-CD8 population in the TG there was a marked enrichment of 
polyfunctional and high functional avidity cells over time within the latently infected TG.  In 
contrast, from 8-14 dpi the non-helped gB-CD8 exhibited a further decline in polyfunctional 
cells, which was particularly prominent among the high functional avidity cells that represented 
only 4% of the non-helped gB-CD8 at 14 dpi (Fig. 12B).  This reduced functionality combines 
with a reduced number of non-helped gB-CD8 in the TG at 14 dpi (Fig. 10A) to define a highly 
compromised gB-CD8 population at this time.  The frequency of polyfunctional cells within the 
non-helped gB-CD8 population increased from 14-35 dpi, but remained significantly reduced 
(p<0.01) relative to their helped counterparts following both optimal and sub-optimal gB peptide 
stimulation.  By 56 dpi, the non-helped gB-CD8 regained full functionality.  The augmentation 
of gB-CD8 functionality was imprinted by CD4+ T cells during the first 8 days after infection 
because depletion of CD4+ T cells beginning at 8 dpi had no effect on gB-CD8 function at 35 dpi 
(Fig. 12C).  
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4.5 LATENTLY INFECTED TG SELECTIVELY PROMOTE THE ENRICHMENT 
OF HIGH FUNCTIONAL AVIDITY GB-CD8 DURING ESTABLISHMENT OF 
MEMORY.   
We have previously demonstrated that the microenvironment of the latently infected TG can 
influence functional properties of the resident gB-CD8 memory population, presumably due to 
persistent low-level exposure to viral antigens (130).  To determine if the increased frequency of 
polyfunctional and high functional avidity gB-CD8 was unique to latently infected TG, we 
analyzed the functionality of gB-CD8 in the non-infected lungs of the same mice at 35 and 56 
dpi (Figure 5A).  As shown in Figure 5B&C, the gB-CD8 population in the lungs already 
showed a high frequency of polyfunctional cells by 35 dpi, and these remained high at 56 dpi.  
Thus, the acquisition of polyfunctional cells over time appeared to be inherent to the transition of 
gB-CD8 into memory.  In contrast, the frequency of high functional avidity cells within both the 
overall responding gB-CD8 population (IFN-γ/LG) and within the polyfunctional (IFN-
γ/LG/TNF) population declined significantly (p<0.01) between 35 and 56 dpi, when they 
constituted only 22% of the gB-CD8 population.  The selective increase (total response p<0.01 , 
polyfunctional p<0.001) in high functional avidity cells in the TG relative to the lungs is 
illustrated in Figures 5D&E.  Thus, while acquisition of polyfunctionality appears to occur 
normally in gB-CD8 during the transition from an effector to memory population, latently 
infected tissue appear to provide a selective pressure for accumulation of high functional avidity 
gB-CD8.  
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 Figure 13- Latent virus influences some of the functional changes that occur in gB-
CD8 during the establishment of memory. 
A) Lungs were harvested at 35 or 56 dpi, dispersed cells were stained with gB498-505 tetramers, and sorted 
gB-CD8 were ≥ 90% gB-tetramer+ as illustrated in a representative dot plot.  Sorted gB-CD8 were stimulated with 
an optimal or suboptimal dose of gB peptide and IFN-γ and TNFα production and lytic granule (LG) release were 
quantified as in Fig. 2.  B) Representative flow plots depicting background activation from tetramer binding, as well 
IFN-γ, TNFα and LG responses to optimal and suboptimal gB peptide stimulation.  C) bars represent mean ± SEM 
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of total (IFN-γ/LG) responders or polyfunctional (IFN-γ/LG/TNF) responders.  The total bar represents the 
frequency of cells responding to optimal gB peptide stimulation, while the bar in bar graph represents the frequency 
of high functional avidity cells responding to a sub-optimal gB peptide dose. D) bars represent the frequency of high 
functional avidity total (IFN-γ/LG) and polyfunctional (IFN-γ/LG/TNF) gB-CD8 responders in the TG and lungs.  
(***p<0.001, **p<0.01, * p<0.05) (n=8-10 mice/group). 
4.6 TCR AFFINITY DOES NOT CORRELATE WITH FUNCTIONAL AVIDITY IN 
NON-HELPED GB-CD8 
The reduced functionality of non-helped gB-CD8 in the TG at 35 dpi could be due to low TCR 
affinity or exposure to a variety of immunomodulatory signals in vivo (179,181,182). To 
differentiate these two types of influences, we employed a tetramer release assay to compare the 
TCR affinity of helped and non-helped gB-CD8 obtained from TG at 35 dpi. As illustrated in 
Figure 14, the non-helped gB-CD8 exhibited an average TCR affinity that was essentially 
identical to that of helped gB-CD8, suggesting that the reduced functionality of the non-helped 
gB-CD8 detected directly ex vivo resulted from in vivo exposure to immunoregulatory 
influences.     
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Figure 14 - TCR affinity does not correlate with functional compromise in non-helped 
memory. 
TGs were harvested and dispersed at 35 dpi.  TG suspensions were stained with gB498-505 tetramer, and then 
incubated with anti-H-2Db/Kb antibody at 37°C for the designated times to observe tetramer dissociation.  Cells were 
then stained with anti-CD8α and anti-CD45 mAb, and analyzed via flow cytometry.  Data represent the mean 
fluorescence intensity (MFI) of CD8+ tetramer+ cells as a percentage ± SEM of the maximum MFI observed at time 
zero. (n=10 mice/group) 
4.7 THE REDUCED FUNCTIONALITY OF NON-HELPED GB-CD8 IS 
ASSOCIATED WITH INCREASED PD-1 EXPRESSION. 
We next determined if the functional compromise observed in non-helped gB-CD8 in TG 
between 8 and 35 dpi was associated with enhanced expression of the inhibitory receptor PD-1. 
At 8 dpi PD-1+ expression was significantly elevated on non-helped gB-CD8 in both the DLN 
(Fig. 15A) and TG (Fig. 15B&C). Increased PD-1 expression was manifest as both an increased 
frequency and increased level (MFI) of PD-1 expression.  The frequency of PD-1+ non-helped 
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gB-CD8 gradually declined in the TG, but remained significantly elevated through 35 dpi. The 
increased PD-1 expression during this time was associated with reduced functionality (Fig. 13A, 
B). By 56 dpi, PD-1 expression on non-helped gB-CD8 in the TG was further reduced and no 
longer significantly different from that on helped gB-CD8; concurrent with complete functional 
recovery.   
 
Figure 15 - The disregulated function of non-helped gB-CD8 is associated with increased PD-
1 expression. 
B6 mice that received HSV-1 corneal infections were not depleted or continuously depleted of CD4+ T 
cells beginning 2 days before infection. DLN were excised at 8 dpi and TG were excised at the designated dpi, and 
dispersed cells were stained simultaneously with anti-CD8α, anti-CD45, anti-PD1, and gB498-505 tetramer and 
analyzed via flow cytometry.  Representative dot plots illustrate PD1 expression (based on isotype control) by A) 
non-CD4-depleted (helped) gB-CD8 in DLN at 8 dpi; and B) helped and CD4-depleted (non-helped) gB-CD8 in the 
TG at 8, 21, and 56 dpi. The mean fluorescence intensity (MFI) and frequency of the PD1+ cells is indicated in each 
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plot C) symbols represent the mean ± SEM frequency of PD1+ helped and non-helped gB-CD8 in the TG at the 
designated dpi.  The wedge under the graph represents the corresponding change in functionality.  *** p<0.001, 
**p<0.01 * p<0.05) (n=8-10 mice/group) 
 
4.8 BLOCKADE OF PD-L1 RESTORES FUNCTION TO NON-HELPED GB-CD8 IN 
THE TG 
Since transient functional dysregulation of non-helped gB-CD8 in TG was associated with 
elevated PD-1 expression, we predicted that blocking PD-1/PD-L1 interaction would restore 
normal function to these cells.  TG were obtained from mice at 35 or 56 dpi following 2 weeks of 
systemic treatment with anti-PD-L1 or control mAb. At 35 dpi the non-helped gB-CD8 in the TG 
of mice that were treated with control mAb exhibited the anticipated reduction in the frequency 
of total gB-CD8 (Fig. 16A) and polyfunctional (Fig. 16C) capable of responding to gB peptide-
pulsed targets.  However, functionality was completely restored to the non-helped gB-CD8 
following 2 weeks of anti-PD-L1 mAb treatment (Fig. 16A&C).  In contrast, anti-PD-L1 
treatment did not influence the function of helped gB-CD8 in TG at 35 dpi, or the function of 
helped or non-helped gB-CD8 in the TG at 56 dpi (Fig. 16B&D).   
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 Figure 16 - Blockade of PD-1L restores function to non-helped gB-CD8 in the TG.   
Untreated and CD4 ablated mice were treated via i.p. injection of 200ug of anti-PDL1 blocking or isotype 
control mAb for 2 weeks prior to A,C) 35 dpi, and B,D) 56 dpi.  dispersed TG were stimulated with an optimal or 
suboptimal dose of gB peptide and IFN-γ and TNFα production and lytic granule (LG) release were quantified as in 
Fig. 2.   Bars represent the mean ± SEM frequency of total (IFN-γ/LG) or polyfunctional (IFN-γ/LG/TNF) helped 
(from non-depleted mice) and non-helped (from CD4-depleted mice) gB-CD8 in control (isotype) and anti-PD-L1 
(αPDL1)-treated mice.  The total bar represents response to optimal antigen, while the bar in graph represents 
response to sub-optimal antigen.  (** p<0.01, * p<0.05,) (n=10 mice/group). 
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 4.9 DISCUSSION CHAPTER 4  
The involvement of CD4+ T cell help in CD8+ T cell responses is complex and likely influenced 
by factors such as the nature of the immunogen, the activation status of APCs, and the 
microenvironment in which the effector and memory CD8+ T cells reside.  Here we employ a 
unique model system in which CD8+ T cell priming occurs in the context of an acute HSV-1 
infection, but the functional properties of the resulting HSV-specific CD8+ T cell memory 
population can then be examined within disparate tissue microenvironments with or without 
persistent antigenic exposure (130). Moreover, in this model persistent low dose antigenic 
exposure in latently infected ganglia does not lead to CD8+ T cell functional exhaustion as is 
seen with chronic viral infections that are characterized by extended exposure to high levels of 
viral antigens following initial infection.  Indeed, in this model long-term functionality of the 
ganglionic gB-CD8+ T cell population is required to maintain the virus in a latent state 
(29,114,180).  We employ this model system to explore the influence of CD4+ T cells on the gB-
CD8 response.   
We demonstrate that CD4+ T cells influence the gB-CD8 response in two ways.  First, the 
gB-CD8 effector population in the TG undergoes a more rapid contraction in the absence of 
CD4+ T cells.  This effect is exerted at the time of contraction as opposed to during the initial 
programming of the naïve gB-CD8, since contraction is accelerated when CD4+ T cell ablation is 
initiated before infection or after the peak accumulation of effector gB-CD8 in the TG at 8 dpi.  
The mechanism by which CD4+ T cells influence CD8+ T cell contraction is currently unclear.  
 62 
 Accelerated contraction alone did not influence the functional characteristics, 
immunosurveillance capability, or size of the gB-CD8 memory pool established in the TG.  Mice 
that were depleted of CD4+ T cells beginning at 8 dpi showed an approximate 50% reduction in 
gB-CD8 at 14 dpi, but the capacity of the remaining CD8+ T cells to maintain HSV-1 latency 
was not compromised as indicated by a similar latent HSV-1 genome copy number in TG.  This 
is probably a reflection of the fact that the remaining gB-CD8 were functionally normal, and that 
at any given time only a small number of latently infected neurons appear to require CD8+ T cell 
protection from reactivation (183).  These findings do establish that CD4+ T cells are not 
required for either the establishment or maintenance of HSV-1 latency in the TG following 
corneal infection. 
Of greater consequence was the influence of CD4+ T cells on the initial programming of 
gB-CD8.  Depriving mice of CD4+ T cell help during the initial programming and expansion 
phase of the CD8+ T cell response to HSV-1 had no effect on the size of the gB-CD8 effector 
population in the TG at 8 dpi.  This contrasts with findings from a flank HSV-1 infection model, 
where CD4+ T  cell deprivation resulted in reduced gB-CD8 effector expansion (184). Important 
differences in the two studies include the strain of HSV-1 used and the route of infection, both of 
which might influence the amount of CD4+ T cell help required for the expansion of HSV-
specific CD8 effector cells.  We also saw no functional differences between the helped and non-
helped gB-CD8 effector cells in the DLN at 8 dpi.  However, the non-helped gB-CD8 did exhibit 
a progressive functional compromise following infiltration of the TG at 8 dpi through 35 dpi.  
The compromise was initially most pronounced among the high functional avidity polyfunctional 
(IFN-γ/LG/TNF) cells at 8 dpi, but progressive loss of the capacity to produce IFN-γ and release 
 63 
lytic granules was observed at 14 and 35 dpi.  The concurrent nature of the functional 
compromise in the non-helped gB-CD8 population in the TG and escape of HSV-1 from latency, 
as indicated by elevated HSV-1 genome copy number, underlines the importance of gB-CD8 
functionality in maintaining HSV-1 in a latent state. 
We previously demonstrated that gB-CD8 are maintained in the latently infected TG of 
IL-15 KO mice, but lost in their non-infected lungs (130).  Those findings were consistent with 
the notion that exposure to viral antigens within the TG supplants the need for homeostatic 
signals in maintaining proliferation and survival of memory gB-CD8.  Latently infected neurons 
express low levels of both MHC class I and viral proteins (106,114).  Based on these 
observations, one might predict that high functional avidity gB-CD8+  that are capable of 
detecting the low epitope densities likely present on latently infected neurons would be best 
suited to provide immunosurveillance and survive within latently infected ganglia.  Our findings 
are consistent with this prediction since high functional avidity gB-CD8 are highly enriched in 
the latently infected TG, but not in the non-infected lungs, and transient compromise in the non-
helped high functional avidity gB-CD8 was associated with failure to maintain HSV-1 latency.  
These findings are also consistent with the recent demonstration that CD8+ T cells in latently 
infected TG represent a tissue-resident subpopulation of memory CD8+ T cell that possess 
unique properties (185). 
In a chronic LCMV infection model, intermediate levels of PD-1 expression on LCMV-
specific CD8+ T cells was associated with partial exhaustion that could be reversed by in vivo 
PD-L1 blockade (115).  In our model, intermediate PD-1 expression (based on both frequency of 
positive cells and level of expression per cell) on non-helped gB-CD8 from 8-35 dpi was 
associated with partial functional exhaustion.  This exhaustion was similar to that seen in the 
 64 
LCMV infection model, with TNF-α being more severely affected before other effector 
mechanisms as exhaustion progressed (186).  Moreover, in vivo blockade of PD-1/PD-L1 
interaction effectively reversed the exhaustion in non-helped gB-CD8.  This is in agreement with 
a recent study that observed that cells that were PD-1int but not PD-1hi were capable of functional 
recovery (187).   
The source of PD-L1 that engages PD-1 on gB-CD8 in latently infected ganglia is not 
clear, but several observations point to latently infected neurons as likely candidates.  First, it 
appears that PD-1 inhibits TCR signaling when the TCR and PD-1 ligands are expressed on the 
same cell (188). Second, extended PD-1/PD-L1 exposure is required for CD8+ T cell functional 
exhaustion and gB-CD8 closely associate and form immunologic synapses with latently infected 
neurons (106,114,115). Finally we have observed PD-L1 expression on neurons in latently 
infected TG (our unpublished observation).   
This of course, begs the question of why non-helped gB-CD8 express higher levels of 
PD-1 than their CD4-helped counterparts.  We cannot formally rule out the possibility that non-
helped gB-CD8 up-regulate PD-1 expression due to encounter with higher levels of viral antigen 
in the DLN or TG.  However, we consider this unlikely because CD4-sufficient and CD4-
deficient mice eliminate replicating virus from the cornea and TG with similar kinetics and 
establish latency with a similar load of viral DNA at 8 dpi.  Instead we favor the hypothesis that 
the threshold level of TCR signaling required for PD-1 expression is set at a lower level when 
gB-CD8 are programmed in the absence of CD4+ T cell help.  The threshold level of TCR 
signaling required to induce PD-1 expression might then be met by non-helped, but not helped 
gB-CD8+ T through encounter with antigen.  Of interest is how the non-helped gB-CD8 pool still 
retained functionality despite elevated PD-1 expression within the DLN at 8 DPI.   We 
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hypothesize concordant expression of costimulatory molecules with PD-L1 on APCs within the 
DLN may slow or prevent the onset of exhaustion.  As these cells enter the TG and undergo 
prolonged interactions with neurons, they undergo progressive functional exhaustion. 
Elucidating the mechanism(s) leading to reduced PD-1 expression and functional recovery of 
non-helped gB-CD8 in HSV-1 latently infected TG between 35 and 56 dpi will require further 
study.  
Several recent reports emphasize the importance of CD8+ T cells in maintaining HSV-1 
in a latent state within the TG. Effective immunosurveillance of latently infected neurons 
requires CD8+ T cells with the capacity to respond to low levels of viral epitopes that likely exist 
on infected neurons.  Our current findings demonstrate that CD4+ T cell help during initial 
programming is important in generating a memory CD8+ T cell population with sufficient 
sensitivity to provide this surveillance.  Since HSV-1 reactivation from latency is the primary 
cause of recurrent herpetic disease, any vaccine designed to prevent reactivation will need to 
incorporate both CD4 and CD8 epitopes. 
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5.0  THE ROLE OF HSV-1 SPECIFIC CELLS IN HERPES STROMAL KERATITIS  
While CD4+ T cells have been implicated in orchestrating HSK, it remains highly contentious 
exactly how these cells mediate this inflammatory disease.  Much debated exists on whether 
HSV-1 specificity is necessary for HSK pathogenesis to occur.  We have isolated and cloned 
HSV-1 specific CD4+ T cells from HSK inflamed corneas in BALB/C mice.  We characterized 
these clones and identified what HSV-1 protein they recognize, and used adoptive transfer 
models to test that hypothesis that these cells can initiate HSK in host mice. 
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5.1 HSV-1 SPECIFIC CD4+ T CELLS ARE PRESENT WITHIN THE INFECTED 
CORNEA 
Previous research by Lepisto et al (unpublished) isolated HSV-1 specific CD4+ T cells from 
HSK inflamed corneas.  These corneas were cultured for several weeks to generate a cell line, 
which was then cloned.   Initial characterizations identified these cell lines were HSV-1 reactive 
by IFN-γ production (Figure 17).  This reactivity clearly establishes the presence of HSV-1 
specific CD4+ T cells cornea at the time of HSK progression.   
                      
Figure 17 – HSV-1 specific cells isolated from HSK inflamed cornea are reactive to HSV-1 
BALB/c mice were infected with 105 PFU of HSV-1 RE. CD4+ T cells were purified from corneas of mice with 
HSK at D+11 P.I. (as described in the Material and Methods) and were cultured until a stable cell line was 
established. This cell line was stimulated with UV-inactivated HSV pulsed DC (UV HSV) or unpulsed DC (no 
HSV) for 72 hrs and supernatants were collected and assayed for IFN-y by standard ELISA. Data represented as 
mean ± SEM pg/mL IFN-γ, data from 2 replicate experiments. 
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5.2 HSV-1 SPECIFIC CLONES RESPOND DIFFERENTIALLY TO HSV-1 
This isolated cell line was cloned by limiting dilution and the isolated clones were tested for their 
HSV-1 reactivity.  When stimulated with HSV-1 antigen loaded APCs, these clones responded 
differentially as measured by the output of IFN-γ.  All clones appeared to be specific for HSV-1, 
but certain clones exhibited to lower reactivity via IFN-γ when compared to others.  This is 
similar to observations in the clinic, where differential HSV-1 reactivity via cytokine production 
is observed from CD4+ T cells isolated from the HSK inflamed cornea. (149,155,189). 
          
 
Figure 18 – Clones respond differentially to HSV-1 with IFN-γ 
 69 
A cross section of clones (A-O) were stimulated with UV inactivated HSV pulsed APCs or unpulsed controls for 72 
hours.  Cells were stimulated at a 1:5 effector to target ratio.   Supernatants were collected and assayed for IFN-γ by 
standard ELISA. Data represented as mean ± SEM pg/mL IFN-γ. (* p<0.05,).  Data from 2 replicate experiments. 
 
5.3 THE HSV-1 SPECIFIC CLONES ARE ALL SPECIFIC FOR GLYCOPROTEIN B 
OF HSV-1 
Next we endeavored to identify the specific HSV-1 antigens that were recognized.  We tested a 
cross section of these clones (both high and low IFN-γ reactive clones) with APCs loaded with 
the lysate of 293 T cells transfected with full length glycoprotein B, D, F, and G.  Surprisingly, 
all clones assayed responded to APCs loaded glycoprotein B with levels similar to that of HSV-1 
antigen loaded APCs (Figure 19), providing strong evidence that the HSV-1 component 
recognized by these clones was located on glycoprotein B.   
 
Figure 19 – HSV-1 specific clones are all specific for HSV-1 glycoprotein B. 
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Representative ELISA data from a “high reactive” and “low reactive” HSV-specific clones.  Cells were stimulated 
with UV inactivated HSV pulsed APCs or APCs pulsed with gB-transfected 293 T cell lysate  for 72 hours.  
Supernatants were collected and assayed for IFN-γ by standard ELISA. Data represented as mean ± SEM pg/mL 
IFN-γ. Data indicative of two independent experiments. 
 
5.4 HSV-1 CLONES ARE OF A TH1 OR TH17 PHENOTYPE 
Further characterization was performed on these clones to identify mechanisms behind the 
differential response of IFN-γ to gB.  We hypothesized that the low IFN-γ reactive cells may be 
of a different helper subset than the high IFN-γ producers.  A number of immunopathologies 
have recently identified a TH17 CD4+ T  cell component, such as rheumatoid arthritis, colitis, 
and experimental autoimmune encephalomyelitis (190,191).  A study looking at human  corneal 
fibroblasts in culture observed that IL-17 can induce heavy production of granulocyte 
macrophage colony-stimulating factor (GMCS-F), a potent chemoattractant for PMN neutrophils 
(192).  This leads us to hypothesize that these low IFN-γ reactive cells may be TH17 cells.  
When high and low IFN-γ reactive cells were stimulated with HSV-1 antigen, and their 
supernatants were analyzed by luminex bead analysis, we observed that the low IFN-γ reactive 
cells did, in fact, produce IL-17 in response to HSV-1 (Figure 20).  This strongly suggests that 
both TH1 and TH17 HSV-1 specific CD4+ T cell subsets are present within the cornea at the 
time of HSK, raising the possibility that there is in fact an IL-17 driven component to HSK 
progression. 
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 Figure 20 – HSV-1 clones respond to HSV-1 with either a T-helper 1 or 17 cytokine 
phenotype 
Luninex bead analysis of HSV-1 stimulated high and low IFN-γ reactive cells.  Cells were stimulated with UV 
inactivated HSV pulsed APCs for 72 hours.  Supernatants were collected and assayed for IFN-γ and IL-17 via 
luminex cytokine bead array. Data represented as mean ± SEM pg/mL IFN-γ or IL-17.  N=2 independent 
stimulations per group. 
 
5.5 CD4 HSV-SPECIFIC CLONES ARE UNABLE TO ENTER THE INFLAMMED 
CORNEA 
Armed with our identification of IFN-γ and IL-17 producing clones, we moved to in vivo studies 
utilizing adoptive transfer of clones into host mice.  We initially used T cell-deficient hosts as 
hosts for the adoptive transfer of our clones.  We hypothesized that both IFN-γ and IL-17 
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producing clones are needed to initiate productive HSK.  Following an established method of 
transfer for CD4+ T  cells in the context of HSK, we adoptively transferred a TH1 and/or TH17 
clone into severe combined immunodeficiency (SCID) mice (151). Surprisingly, we did not see 
any HSK develop in our host mice, regardless of whether they got either a TH1 (Clone AA), 
TH17 (Clone A), or both clones; mice receiving CD4+ T  cells from the draining lymph nodes of 
an acutely infected WT mouse did develop HSK normally (Figure 21).   SCID mice receiving 
clones also did not control viral skin disease effectively, impeding HSK severity evaluations. 
                                           
Figure 21 – SCID mice receiving HSV-1 Clones do not develop HSK or control skin disease 
SCID mice hosts received 5x106 clones A or AA, or 2.5x106 of both clones at 2 dpi via i.v. injection.  T cell clones 
were activated via CD3/CD28 prior to transfer. A control group of mice received 5x106 MACS purified CD4+ T 
cells from 7 dpi DLN from a WT BALB/c donor. All mice received regular 4mg/mL ACV in drinking water to 
control viral replication starting at 7 dpi.  HSK and skin disease were evaluated every 2 days from 7 to 17 dpi (n=8 
mice/group). 
 73 
 Further analysis of these mice via flow cytometry revealed that no CD4+ T cell clones 
infiltrated the infected cornea (Figure 22A).  Examination of the spleens of these mice revealed a 
small population of these clones did take up residence, implying that these clones survive within 
the host following adoptive transfer (Figure 22B).  We also looked within the TG, and saw little, 
if any infiltration of our clones (data not shown), suggesting that these cells were impaired in 
infiltrating into the TG and cornea.  This raises a major concern that these clones may not be 
functionally capable of acting as a model effector cell when transferred into a host mouse. 
 
Figure 22 – HSV-1 Clones survive adoptive transfer into SCID hosts, but do not enter the 
infected cornea 
SCID mice hosts received 5x106 clones A or AA, or 2.5x106 of both clones at 2 dpi via i.v. injection.  T cell clones 
were activated via CD3/CD28 prior to transfer. A control group of mice received 5x106 MACS purified CD4+ T 
cells from 7 dpi DLN from a WT BALB/c donor. At 17 dpi, corneas and spleens were dispersed into single cell 
suspension and stained with antibodies for CD4, CD8α and CD45.  Representative flow plots of A) Corneas and B) 
spleens are shown gated on CD45+ cells. (total data n=4-6 mice/group) 
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 A number of different approaches were attempted with our adoptive transfer model in 
hopes of observing more effective peripheral migration of clones in vivo: method of activation 
the clones, time of transfer after or before infection, and host mouse strain (CD4-/-, RAG, and 
SCID models) (Data not shown). No approaches resulted in these HSV-1 specific CD4+ T cell 
clones entering the infected cornea.  With this alarming observation considered, we moved on to 
an adoptive transfer method where we could track infiltration of our cells with a high resolution 
within an immunologically intact animal.   
We repeated our adoptive transfer approach of our clones into Thy 1.1 hosts, which have 
a small congenic change to the Thy 1 receptor.  Thy 1.2 is expressed on the HSV-1 specific 
clones, which allows us to track these cells via antibodies to Thy 1.2 and 1.1.  As seen in Figure 
23A, we could track these cells effectively within the blood of these mice at various points 
following infection; donor clones remained stable at 4% frequency in the blood from 11-15 dpi, 
before doubling in frequency to 10% of all CD4+ T cells within the blood at 21 dpi.  When we 
looked within the cornea, we observed a low level of infiltration of our clones (Figure 23B).  At 
the later stages when HSK has progressed to severe disease (15 and 21 dpi), our clones make up 
1% of the infiltrating CD4+ T cells.  This is 4 fold and 10 fold lower than the frequency within 
the blood at 15 and 21 dpi, respectively.  Given that all of these cells are HSV-1 specific, we 
anticipated enrichment in frequency as these cells infiltrate the cornea, not a sharp decline.  
Lepisto et al has observed that the frequency of HSV-1 reactive CD4+ T cells within the cornea 
at 17 dpi is ~20% (193).  The clones were significantly lower than the normal frequency of HSV-
1 reactive cells infiltrating into the infected cornea. Given that we and others are able to see 
robust of WT CD4+ T cells into the cornea following adoptive transfer, this deficiency appears to 
be restricted to our CD4+ T cell clones. (Figure 22)    
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Figure 23 – HSV-1 CD4+ T cell clones are impaired in entry into the cornea in 
immunocompetent hosts 
Thy 1.1 mice hosts received 2.5x106 of Clone A and AA at 2 dpi via i.v. injection.  T cell clones were activated via 
CD3/CD28 prior to transfer.  At 11, 15, and 21 dpi, blood and corneas were harvested for flow cytometric analysis 
and stained with antibodies for CD4, CD45, Thy 1.1, and Thy 1.2.  Representative flow plots of A) the blood and B) 
blood are shown gated on CD45+ cells. (n=6-8 mice/group) 
5.6 HSV-1 SPECIFIC CD4+ T CELL CLONES CONSTITUTIVELY EXPRESS CD43 
AND ARE IMPAIRED IN VLA-4 EXPRESSION 
We further examined our clones phenotypically for potential mechanisms as to why these clones 
have impaired infiltration into the cornea.  When resting and activated clones are phenotypically 
characterized, we do observe a number of stark differences in the expression of activation and 
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adhesion molecules to what is normally expressed on naïve and effector CD4+ T cells in vivo.   
When we examine our clones under resting conditions, we found that they constitutively express 
the activated isoform of CD43, a T cell activation marker normally expressed on effector T cells 
(Figure 25A) (194).  We also checked two of the primary adhesion molecules that effector T 
cells require to efficiently enter peripheral sites of infection, LFA-1 (CD11a), and VLA-4 
(CD49D) (195-197). As depicted in Figure 25B, we establish that activated clones (as defined by 
CD69 expression; data not shown) do express LFA-1 (100%), but do not upregulate VLA-4 
effectively (Clone A 12%, Clone AA 19%).   
 
Figure 24 – Clones have dysregulated CD43 expression and fail to upregulate VLA-4 when 
activated. 
Clones under resting conditions or stimulated with anti-CD3/CD28 for 24 hours were analyzed via flow cytometry.  
Cells were stained with CD4, CD43, VLA-4, and CD11a. Representative flow plots depicting A) CD43 expression 
on resting clone A and AA, and B) CD11a and VLA-4 co-expression on activated Clones. (total data is indicative of 
3 replicate experiments) 
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  These observations lead us to conclude that these T cell clones have too many phenotypic 
differences from that of an effector cell in vivo.  This renders it difficult to accurately test the 
hypothesis that HSV-1 specific cells are necessary for the HSK development.  Efforts were taken 
early in these studies towards the generation of a CD4+ T cell TCR transgenic mouse.  At the 
time of this dissertation, pups have been successfully generated for both the alpha and beta TCR 
chains. 
 A few key observations from the development of the TCR transgenic mouse need to be 
mentioned here in order to properly discuss the findings presented by this study.  Corroborating 
early phenotypic analysis of the clones, we observed all cells have the identical V-beta TCR 
chain by sequencing.  Surprisingly we also found that the cells have identical TCR V-alpha 
chains and the variable regions of both TCR chains of the cell line and clones were identical by 
sequencing.   This piece of evidence demonstrates the T cell line is a homogeneous population of 
cells, and suggests other factors may control why certain clones exhibit a TH1 or a TH17 
phenotype. 
5.7 DISCUSSION – CHAPTER 5  
The mechanism by which CD4+ T cells initiate the complex cascade of events that leads to HSK 
remains contentious after years of concentrated study.  Here we find that HSV-1 specific T cells 
can be isolated from the cornea during the initial stages of HSK progression.  This corroborates 
with a previous study identifying HSV-specific CD4+ T  cells within the cornea both during HSK 
progression and during its chronic phase (193).  A number of clinical studies have also observed 
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HSV-specific cells isolated from the corneal buttons from patients with necrotizing keratitis 
(149,155,198).   Furthermore, we find that all of our clones are specific for glycoprotein B.  This 
bares startling (though probably coincidental) similarity to the B6 model of infection, where the 
CD8+ T  cell immunodominant epitope is also directed at gB (105).  The only other group of 
studies attempting to identify CD4+ T  cell viral specifities have also observed that a “late” viral 
protein glycoprotein D was recognized (199,200).  
The observation the T cell clones were specific for gB was a surprising observation.  
Furthermore the T cell line these clones were derived from responds equally as well to gB as it 
does to HSV-1, strongly suggesting that all cells within the T cell respond to the same antigen.  
When sequencing of the TCR of the clones and their parent cell line was undertaken, all cells had 
the identical alpha chain (Vα8.2) and beta chain (Vβ8.3), including all hyper variable regions. 
This is indicative that the T cell line at the time of cloning was a single population of cells, based 
on their TCR.   There a number of possibilities to account for this observation.  Firstly, the 
selective pressures during the cell line passaging may have driven the outgrowth of a diverse 
repertoire of T cells within the cell line to a single specificity over time.  Another alternative 
could be the cells specific for HSV-1 at the time of harvest for may have been all of one clone 
and specificity.  While unlikely, it possible that an immunodominant epitope to HSV-1 is 
recognized early, thus driving a homogenous response of HSV-specific T cells into the cornea 
early; it is likely that if this is the case, the repertoire of T cells recognizing HSV-1 antigens 
would expand as HSK progression continues. 
Previous work has observed that these clones direct a differential response (via IFN-γ) to 
HSV-1 antigens, and here we have continued these studies by identifying some clones produce 
IL-17, fitting a TH17 phenotype, while others produce IFN-γ, matching up with that of a TH1 
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phenotype.  This observation has some profound implications, given that the cells all recognize 
glycoprotein B and the TCR of these cells is identical.  It raises the question of how, when, and 
where did these cells diverged functionally.  One possibility is this is an artifact of the T cell line 
growth and passaging; this appears unlikely, as the cells were passaged by CD3/CD28 
stimulation, which has no precedence in the literature for causing divergence of a T cell helper 
phenotype.  The second possibility remains that this change in effector subset machinery 
occurred in vivo, either in the draining lymph nodes during priming or following the entry of 
these cells into the cornea. There have been observations that the dogmatic mantra of 
“commitment to functional subset” may be more dynamic than previously understood.  A 
handful of studies looking at natural T-regs have observed a loss of FoxP3 expression and a shift 
towards a classical memory T cell phenotype and functionality, notably the ability to produce 
IFN-γ (201-203).  A study from the clinic found T-regs that had lower levels of FoxP3 could 
revert to a TH17 phenotype in patients suffering from a flare of systemic lupus erythematosus 
(204).  Another study reported that RORγT, previously established as a “defining” transcription 
factor for TH17 cells is also found in FoxP3+ T-cells, and that T-regs are capable of shifting to a 
TH17 phenotype when levels of TGF-β decline locally (205).  One group also observed an 
identified T cell subset isolated from the draining lymph nodes can produce IFN-γ, but when 
isolated from the gut parenchyma produces IL-17 (202).  Taken together, it appears that based on 
local microenvironmental factors, the once thought stable T helper subsets may be capable of 
changing based on the milieu of signals around them. 
When one studies the cornea, we find that it is characterized by high levels of TGF-β 
under steady state conditions (43-46).  It is thought the high levels of this immunomodulatory 
cytokine help maintain immune privilege within the cornea.  As HSK development begins, large 
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numbers of cytokines are present within the cornea, most notably IL-6 (206,207).  This provides 
a potential shift in the microenvironment towards concentrated local amounts of IL-6 and TGF-β 
in the cornea at the onset of HSK.  It is within the realm of possibility that clonally expanding 
CD4+ T cells can shift from either a T-regulatory or TH1 phenotype to that of a TH17 phenotype 
as they persist within the cornea. As new cells infiltrate into the cornea they would still retain 
their initial phenotype for a short period of time.  This could explain why a mix of cells with 
identical TCR could have diverged to both a TH17 and TH1 phenotype.  We will have to await 
the generation of the transgenic TCR mouse in order to properly address this hypothesis. 
We identified these cells are functionally impaired in their ability to enter the cornea and 
ganglion after infection, a trait not shared by isolated CD4+ T  cells from a host animal.  We 
found that these cells have dysregulated expression of the activated isoform of CD43, and also 
failed to upregulate VLA-4 when stimulated.  These findings are instructive to why these cells 
fail to behave as an effector T cell would in vivo.  CD43 has been implicated in negatively 
regulating T cell activation and also in negatively controlling T cell migration, especially into 
immune privileged sites such as the CNS (194,208).  One potential mechanism for this regulation 
of migration is an observation that galectin-CD43 interactions can cause T cell death (209). 
Furthermore, galectin expression has been reported within the cornea (210).  It possible that 
these clones, upon entry within the cornea, retain high levels of CD43 and may undergo 
preferential cell death from prolonged galectin-CD43 interactions.  The more likely explanation 
for this low level infiltration into the cornea by the T cell clones is due to their lack of VLA-4.  A 
recent study singled out VLA-4 as being the most important adhesion molecule for effector 
CD4+ T  cell infiltration into the infected cornea (211).  As these cells lack expression of VLA-4 
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and also could be induced to undergo cell death if they gain entry to the cornea, it is not 
surprising we see poor infiltration of our cells into the infected cornea.   
While we have identified many key phenotypic and functional characteristics of the 
HSV-specific T cell clones, we still were unable to adequately address the overarching 
hypothesis of this aim: to test if HSV-1 specific cells are necessary for HSK.  However, we have 
found that these cells are a mix of both TH1 and TH17 subsets, and have identical TCRs, 
suggesting that the microenvironment of the cornea may be altering T helper subset machinery as 
HSK begins.  This raises the possibility that HSV-1 specific TH17 cells may trigger the early 
events in HSK, being driven from either a TH1 or even T-reg phenotype by the unique 
microenvironment of the cornea.  As TH1 cytokines have been identified to be important in 
HSK, it is likely that TH1 T cells as well as bystander activated cells continue mediating the 
ongoing inflammation initiated by TH17 cells (Figure 25).  Unfortunately, the TCR transgenic  
mouse under development will be needed to properly address these newly generated hypotheses. 
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 Figure 25 – Model for T helper subsets and their contribution to herpes stromal keratitis 
We propose that either resident T-regs or TH1 CD4+ T cells may be shifting towards an IL-17 phenotype early in 
HSK development, providing the needed inflammatory signals to ramp up t pathogenesis of keratitis.  Once high 
levels of inflammatory mediators are established, TH1 HSV-1 specific CD4+ T cells and as time goes on, bystander 
activated cells, contribute to the chronicity of disease. 
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6.0  THE ROLE IL-12 SUBUNITS IN HERPES STROMAL K ERATITIS  
Interleukin (IL)-12p40 can couple with IL-12p35 or p19 chains to form the molecules IL-12p70 
and IL-23, respectively that promote TH1 cytokine responses.  IL-12p35 can bind to EBI3 to 
form an anti-inflammatory molecule IL-p35, but a proinflammatory function of IL-12p35 
independent of IL-12p40 has not been described.  IL-12 has been previous implicated in the 
progression of herpes stromal keratitis.  Here we observed the roles of IL-12p35 and IL-12p40 in 
a mouse model of HSK.  
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6.1 MICE LACKING THE IL-12P35 SUBUNIT DEVELOP TRANSIENT HSK 
The corneas of IL-12p35-/-, IL-12p40-/-, IL-12p35-/-p40-/- (double knockout), and WT mice were 
infected with HSV-1. All four strains of mice developed moderate to severe HSK marked by 
increasing corneal opacity and peripheral neovascularization by 15 dpi (Fig. 1). HSK severity 
progressed steadily through 21 dpi in both WT and IL-12p40-/- mice with complete opacity, 
expanded neovascularization encroaching from the periphery into the central cornea, and corneal 
edema. In contrast, HSK severity began to regress by 15 dpi and 11 dpi in IL-12p35-/- mice and 
IL-12p35-/-p40-/- mice, respectively.  Disease regression in both groups of IL-12p35 deficient 
mice was marked by rapidly decreased peripheral opacity with thinning of peripheral vasculature 
and a more gradual decrease in central opacity. 
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Figure 26 – Mice lacking IL-12 develop HSK 
IL-12p35-/-, IL-12p40-/-, IL-12p35-/-p40-/- (double knockout), and WT mice infected with HSV-1 RE were 
scored for HSK by slit-lamp examination from 7 – 21 dpi.  Data shown reflect n values of at least 5 mice per group 
and are representative of 2 or more independent experiments. 
6.2 CORNEAL INFLAMMATORY INFILTRATE OF MICE LACKING IL-12P35  
Early in HSK development (13 dpi) the infected corneas of WT, IL-12p35-/-, IL-12p40-/-, and IL-
12p35-/-p40-/- mice showed comparable infiltrates of CD4+ T cells and Gr1bright neutrophils (Fig. 
2A), which comprised the majority of the bone marrow-derived CD45+ cells in the cornea (data 
not shown).  At 17 dpi, IL-12p35-/-p40-/- mice exhibited a significant reduction in neutrophilic 
infiltrate and a reduction in the mean number of CD4+ T cells in the cornea that did not achieve 
statistical significance (Fig. 2B).  The composition of the corneal infiltrate in the p35-/- and p40-/- 
mice at 17 dpi was not significantly different than that of WT mice.  At the peak of HSK severity 
(21 dpi), both IL-12p35-/- and IL-12p35-/-p40-/-  mice showed significantly reduced numbers of 
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CD4+ T cells and neutrophils within their corneal infiltrates relative to WT mice (Fig. 2C).  In 
both IL-12p35-/- and IL-12p35-/-p40-/- mice reduction in clinical HSK severity preceded changes 
in the composition of the inflammatory infiltrate in the cornea by approximately 2 days.  The 
p40-/- mice had a significantly higher CD4+ T cell and neutrophilic corneal infiltrate than WT 
mice at 21 dpi, though this did not translate into a higher clinical HSK score (Fig. 1).   
 
 
Figure 27 - Mice lacking IL-12p35 have a reduced corneal leukocytic infiltrate 
At 13, 17, and 21 dpi, corneas were dispersed into single cell suspensions and stained with anti-CD45, 
CD4, and Gr-1 mAb. Cell suspensions were analyzed by flow cytometry. Data are represented as mean ± SEM 
number of CD4+ T cells (Left axis), and GR-1bright neutrophils (Right axis).  Data reflect the average of 2 
independent experiments with n values of at least 4 corneas per group. (* p < .05; ** p < .01.) 
 
We hypothesized that the HSK regression would be associated with an increased frequency of 
CD4+ CD25+ FoxP3+ Tregs in the corneas of p35 deficient mice.  In fact, the CD4+ T cell 
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population in the corneas of IL-12p35-/- mice did show an increased frequency of CD25+ FoxP3+ 
cells during HSK regression at17 dpi (Fig. 3).  However, an increased frequency of Tregs was 
not observed in the IL-12p35-/-p40-/- mice despite more rapid HSK regression (Fig. 3).   
 
6.3 NATURAL TREGS DO NOT ACCOUNT FOR HSK REGRESSION IN IL-12P35-/- 
MICE 
To determine if the increased frequency of CD4+ CD25+ FoxP3+ cells in infected corneas of 
12p35-/- mice was responsible for HSK regression, we determined if in vivo depletion of CD25+ 
cells prior to HSV-1 corneal infection would alter the course of HSK in these mice.  A single 
treatment with 100 µg of anti-CD25 mAb or control mAb 3 days before HSV-1 corneal 
infection, effectively depleted CD25+ Foxp3+ cells from corneas through 21 dpi (Fig. 4A).   
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 Figure 28 - IL-12p35-/- corneas contain an increased Treg population during disease regression.  
Corneas were dispersed into single cell suspensions at 13 and 17 dpi and were stained with anti-CD4, 
CD25, and Foxp3 mAb. Corneal suspensions were analyzed by flow cytometry.  Data are represented as 
mean % ± SEM CD25+FoxP3+ cells in the CD4+ T cell population.  Groups consisted of 5 or more 
individual corneas and results reflect the average of 2 independent experiments. (* p < .05, *** p < .001.)  
 
However, Treg depletion did not significantly impact the course of HSK in IL-12p35-/- 
mice, with both depleted and non-depleted mice exhibiting HSK regression (Fig. 4B).  As 
established in previous studies(212,213), Treg depletion did significantly increase the leukocytic 
infiltrate in infected corneas of WT mice (Fig. 4C), but did not significantly influence the size of 
the infiltrate in corneas of IL-12p35-/- mice (Fig. 4D).  Thus, while CD25+ Tregs do modulate 
HSK severity in WT mice, they do not account for HSK regression in mice lacking IL-12p35.  
However, it is noteworthy that there remained in the corneas of the anti-CD25 mAb-treated IL-
12p35-/- mice a substantial population of CD4+ FoxP3+ cells that did not express CD25 (Fig. 4A).  
These cells did not stain with anti-rat Ig, suggesting that CD25 was not simply masked by the rat 
anti-mouse CD25 mAb used for depletion.  A contribution of these FoxP3+ cells to HSK 
regression cannot be ruled out. 
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 Figure 29 - Regulatory T cells do not cause disease attenuation in IL-12p35-/- mice. 
IL-12p35-/- and WT mice were ~80% depleted of Treg cells by treatment with anti-CD25 mAb (PC61) 3 
days prior to infection with HSV-1 RE (A, comparing depletion in WT mice). WT and IL-12p35-/- mice were 
followed for HSK (data not shown and B, respectively), and at 21 dpi, dispersed corneas were stained with anti-
CD4, CD8, CD45, and GR-1 and analyzed by flow cytometry (WT, C and IL-12p35-/- D). Data are represented as 
mean ± SEM number of cells per cornea.   Results represent the average of 2 independent experiments with an n 
value of at least 6 mice per group. * p < .05. 
 
6.4 IL-12P35 INFLUENCES THE CYTOKINE AND CHEMOKINE PROFILE IN 
INFECTED CORNEAS 
To determine if HSK progression and regression was associated with different chemokine and 
cytokine profiles, corneas of WT, IL-12p40-/-, IL-12p35-/-, and IL-12p35-/-p40-/- mice were 
 90 
excised at 17 dpi, and cytokine and chemokine proteins were quantified using a multiplex bead 
array assay (Fig. 5).  During HSK regression (17 dpi) the corneas of both IL-12p35-/- and IL-
12p35-/-p40-/- mice exhibited significantly reduced expression of the neutrophil chemoattractants 
KC/CXCL3 (Fig. 5A) and MIP-2/CXCL2 (Fig. 5B), relative to those of WT mice.  This 
correlated with a reduction in the neutrophilic infiltrate in IL-12p35-/-p40-/- mice and slightly 
preceded their reduction in IL-12p35-/- mice (Fig. 2B).  In conjunction with a reduced CD4+ T 
cell infiltrate, the corneas of IL-12p35-/- and IL-12p35-/-p40-/- mice also exhibited significantly 
reduced levels of the chemotactic factor MCP-1/CCL2 (Fig. 5C), a chemokine that one study 
suggested regulates CD4+ T cell infiltration into infected corneas(214).  The attenuation of blood 
vessels in infected corneas of IL-12p35-/- and IL-12p35-/-p40-/- mice was also associated with 
significantly reduced levels of the angiogenic factor VEGF (Fig. 5D).  Infected corneas of IL-
12p40-/- mice compared to infected WT corneas exhibited elevated levels of MIP-2/CXCL2 and 
VEGF, but similar levels of KC/CXCL3 and MCP-1/CCL2.  The increased levels of MIP-
2/CXCL2 and VEGF preceded the increased leukocytic infiltrate at 21 dpi (Fig. 2C), but were 
not associated with increased clinical HSK scores (Fig. 1).  Of interest was the lack of detectable 
levels of IL-6 within the corneas of the IL-12p35-/- mice while levels of this cytokine were 
similar in WT, IL-12p40-/-, and IL-12p35-/-p40-/- mice (Fig. 5E).  As mice lacking IL-12 p35 still 
underwent a regression of disease (Fig. 1), it appears IL-6 while important for HSK 
development, is not alone sufficient to promote HSK progression. 
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 Figure 30 - Absence of IL-12 alters expression of cytokines and chemoattractants in corneas. 
WT, IL-12p35-/-, IL-12p40-/-, and IL-12p35-/-p40-/- corneas were harvested at 17 dpi.  Corneas were 
homogenized by sonic dismembranation in PBS + protease inhibitor, and analyzed by multiplex bead array for 
cytokine and chemokine expression. Data are represented as mean ± SEM pg/ml of analyte.   Groups consisted of 5 
or more corneas and results were averaged between two independent experiments. (* p < .05, ** p < .01.) 
6.5 DISCUSSION CHAPTER 6  
The established regulatory role of TH1 cytokines in HSK immunopathology strongly implicates 
the involvement of the IL-12 cytokine family. Indeed, a previous study using the same BALB/c 
WT, IL-12p40-/-, and IL-12p35-/- mice employed in our study supported a role for IL-12 in HSK 
by showing reduced HSK in IL-12p35-/- mice and no HSK in IL-12p40-/- mice (175). The authors 
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concluded that IL-12 was required for HSK. Those findings stand in stark contrast to the findings 
in this report. In our hands IL-12p40-/- mice developed HSK with similar kinetics and severity to 
that seen in WT control mice.  Indeed, infected corneas of IL-12p40-/- mice exhibited a more 
robust inflammatory infiltrate at the peak of HSK (21 dpi) compared to their WT counterparts.  
These findings demonstrate that in our HSK model neither IL-12 nor IL-23 has a requisite role in 
HSK development since both molecules incorporate an IL-12p40 chain.  We further establish 
that the IL-12p35 chain has a requisite role in the progression of HSK beyond 11 dpi, which is 
independent of the IL-12p40 chain as indicated by the transient nature of HSK in corneas of IL-
12p35-/- mice and IL-12p35/p40 double knockout mice.  The genotype of all the mice used in 
these experiments was confirmed by PCR, and the pattern of HSK was observed in multiple 
experiments.   
We surmise that a likely explanation for the differences in findings of the two studies lies 
in the virus used to infect the mice. Ghiasi and colleagues used the McKrae strain of HSV-1 at an 
infectious dose of 2 x 105 PFU to infect corneas. The McKrae strain is highly neurovirulent and 
at the dose employed only 20% of WT and IL-12p40-/- mice and 50% of IL-12p35-/- mice 
survived to the time of HSK evaluation. Thus, in that study HSK was evaluated only in those few 
mice that survived the infection, and the general health of those surviving mice was not 
described. Our study employed a much less neurovirulent RE strain of HSV-1 at a much lower 
infectious dose that induced HSK in 80-100% of WT mice while permitting 100% survival with 
no clinically apparent disease other than HSK. We previously established that HSK is highly 
dependent on the function of CD4+ T cells at the RE HSV-1 infectious dose used in these studies 
(193), and our model better reflects human disease where infections are rarely fatal and HSK 
usually occurs in otherwise healthy individuals. One interesting parallel between the two studies 
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is the fact that the IL-12p35 chain appears to function independent of IL-12p40; in our study 
prolonging HSK and in the previous study enhancing the lethality of HSV-1 infection.  These 
findings are consistent with an important role for IL-12p35 in regulating the immunopathology 
in the cornea and in the CNS independent of IL-12p40. 
The IL-12p40 chain can form an IL-12p40 homodimer, which has been shown to inhibit 
T cell responses by binding to the IL-12Rβ1 chain and inhibiting binding of IL-12 and IL-23 
(165,166). We considered the possibility that IL-12p35-/- mice might have a propensity to 
produce more IL-12p40 homodimer, which might account for the transient nature of HSK in 
these mice. This possibility was addressed by monitoring HSK in mice that lack both the p35 and 
p40 subunits. We observed a transient pattern of HSK in the double knockout mice that was 
similar to that seen in IL-12p35-/- mice. These findings demonstrated that HSK regression was 
due to the lack of the IL-12p35 subunit rather than to an altered function of the IL-12p40 subunit.  
The increased level of infiltrate within the IL-12P40-/- corneas is in agreement with the recent 
study in IL-23 deficient mice, where more severe HSK lesions develop over WT mice(176).  
However, the observation that mice deficient in both IL-12p35 and p40 regress in HSK earlier 
than IL-12p35-/- mice suggests more complex relationships exist for p40 in the development of 
HSK. 
We were intrigued by the dramatic increase in the frequency of Foxp3+ Tregs in the 
infected corneas of IL-12p35-/- mice during HSK regression. The reduced overall CD4+ T cell 
population in the infected corneas of IL-12p35-/- mice during HSK regression, combined with the 
elevated frequency of Tregs among the CD4+ T cells would suggest a very high Treg: effector T 
cell ratio in the infected corneas of these mice. The cytokine TGF-β regulates the differentiation 
of CD4+ T cells into Tregs and into TH17 cells, with co-stimulation by IL-6 favoring the latter 
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(215,216). We noted dramatically reduced levels of IL-6 in the corneas of IL-12p35-/- mice 
during HSK regression when compared with those of WT mice with progressive HSK. The 
known presence of TGF-β in the cornea (44,217) and  the low levels of IL-6 in the corneas of IL-
12p35-/- mice might provide a cytokine milieu that favors the differentiation and/or expansion of 
Tregs.   
However, depletion of CD25+ cells failed to influence HSK regression in IL-12p35-/- 
mice.  The possible explanation that our anti-CD25 treatment effected HSK regression by 
inadvertently depleting CD4+ effector T cells along with Tregs appears highly unlikely.  In our 
hands the majority of CD4+ CD25+ cells in infected corneas co-express Foxp3 (not shown) 
suggesting that predominantly Tregs would be depleted by anti-CD25 treatment.  Moreover, 
similar anti-CD25 mAb treatment increased CD4+ T cell numbers and augmented the overall 
leukocytic infiltrate in HSV-1 infected corneas of WT mice, suggesting that the CD4+ T cells 
that mediate HSK do not express CD25.  To further corroborate this evidence, IL-12p35-/-p40-/- 
did not exhibit any increase in Treg frequency in their corneas, despite HSK regression.  Thus, 
although the frequency of CD4+ CD25+ Foxp3+ Tregs is dramatically increased in infected 
corneas of IL-12p35-/- mice during HSK regression, these cells are either inactive or their 
effector molecules inhibit an IL-12p35-dependent activation pathway.  However as noted above, 
depletion of CD25+ cells leaves a substantial population of CD4+ FoxP3+ CD25- cells in the 
cornea that might contribute to HSK regression.   
Our findings demonstrate that IL-12p35 and p40 regulate the production of several 
chemokines and cytokines in corneas with HSK.  Levels of the macrophage chemoattractant 
MCP-1/CCL2 were significantly and equivalently reduced in infected corneas of IL-12p35-/- and 
IL-12p35-/-p40-/- mice at 17 dpi. This observation is consistent with a role for IL-12 in regulating 
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production of this chemokine. A recent study does suggest a role of MCP-1 in regulating the 
infiltration of CD4+ T  cells into the HSK inflamed cornea (214), although such studies are 
complicated by the fact that MCP1-/- mice exhibit enhanced IL-12 production and increased HSK 
(218,219).  Together these findings suggest a regulatory circuit in which IL-12 induces MCP-
1/CCL2 production, while MCP-1/CCL2 provides feedback inhibition of IL-12 production.   
We also observed that IL-12p35 regulates neutrophil infiltration and production of the 
neutrophil chemoattractants KC/CXCL3 and MIP-2/CXCL2 as these chemokines were 
significantly reduced in infected corneas of IL-12p35-/- and IL-12p35/40-/- mice relative to WT 
mice.  This function of IL-12p35 is independent of IL-12p40 since neutrophilic infiltration and 
levels of these chemokines were somewhat elevated in infected corneas of IL-12p40-/- mice.  
These findings are consistent with previous studies identifying KC/CXCL3, and to a greater 
extent MIP-2/CXCL2 as important factors for neutrophil recruitment and HSK development 
(220-222). 
Several studies have established a critical role for neovascularization in HSK progression 
(206,206,207,223-225).  Here we demonstrate that IL-12p35 independent of IL-12p40 regulates 
VEGF production in corneas with HSK.  In fact, IL-12p40 appears to inhibit the induction of 
VEGF production by IL-12p35 as corneas of IL-12p40-/- mice exhibit dramatically increased 
VEGF production whereas the IL-12p35/p40 double knockouts show reduced VEGF levels 
comparable to those seen in IL-12p35 single knockouts.   
The current understanding of IL-12p35 synthesis indicates that this subunit is not released 
by cells unbound (226). The recent description of IL-35, a IL-12p35 EBI3 heterodimeric sets the 
precedence for more p35 binding partners (170,226). The exact contribution of IL-12p35 subunit 
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to the maintenance of HSK remains unclear, but reflects an exciting development in the study of 
the IL-12 cytokine family in the pathogenesis of HSK immunopathology. 
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7.0  THE ROLE OF DENDRITIC CELLS IN CONTROL OF HSV-1 OCULAR INFECTION 
A number of studies have recently identified that the local APCs that reside or infiltrate a site of 
infection may diverge from the classic notion of antigen uptake for presentation in the lymph 
node, as discussed in the introduction.  Here we examined the role of local resident and early 
recruited DCs within the cornea after HSV-1 infection and how they contribute to the immune 
response.  We took advantage of CD11c-DTR transgenic mice, which contain the high affinity 
human diphtheria toxin (DT) receptor only on CD11c+ DCs.  We used local depletion only 
within the cornea as well as systemic depletions to effectively dissect the roles of both resident 
and responding DCs within the cornea in ocular HSV-1 infection. 
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7.1 CD11C-EGFP+ DC CAN BE DETECTED WITHIN THE NORMAL CORNEA  
Within the normal cornea we have recently identified, using CD11c-DTR mice, the presence of a 
distinct population of CD11c+ DCs that reside at the epithelial stromal interface (Knickelbein et 
al., publication accepted). Given this novel observation, studies were undertaken to identify their 
function in the context of HSV-1 ocular infection.  In the studies here, we used chimeras 
reconstituted with the bone marrow from CD11c-DTR hosts.  This ensures that only bone 
marrow derived CD11c+ cells are ablated following diphtheria toxin (DT) treatment, as reported 
in previous studies (227).  For the purpose of this chapter, unless specified, we shall call these 
bone marrow chimeras CD11c-DTR mice. As seen in figure 31 we can detect pCD11c-
EGFP+CD11c surface+ cells within the cornea.  The peripheral region of the cornea contains a 
more dense concentration of DCs that begins to the thin as one moves toward the central regions 
of the cornea.  These DCs within the cornea are of the classic dendritic morphology.  These DCs 
are bright for pCD11c-EFGP, but also have dim surface CD11c expression.  
A recent study observed that the cornea requires at least 5-6 weeks for full reconstitution 
following irradiation (228).  As indicated in Figure 32, we can see that at 1 month post 
reconstitution – a time frame most studies rely on for “complete reconstitution,” the cornea is not 
completely reconstituted with dendritic cells.  However, by 6 weeks post reconstitution we see 
similar levels of DCs within the central cornea as an intact regular CD11c-DTR mouse.  This 
time frame for corneal recovery is similar to what was previously reported.  
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 Figure 31 – CD11c+ DCs are present within the normal cornea.   
Naïve corneas from CD11c-DTR mice were stained with anti-CD11c antibody, fixed and whole mounted onto slides 
for confocal analysis. Images are representative serial Z-stack confocal microscopy images. The top set of images 
portrays a cross sectional view of the image, with the anterior cornea top, moving down into the corneal stroma.  
The lower sets of images depict a set of images looking downwards into the corneal stroma, moving from the 
peripheral cornea right towards the central cornea.  Representative images (n=4 mice, 2 independent experiments) 
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Figure 32 – CD11c-DTR Bone Marrow Chimeras require 6 weeks for full reconstitution of 
the cornea. 
WT BALB/C mice were dosed with 1000 rads, and reconstituted with 2x105 bone marrow cells from CD11c-DTR 
donors.  At indicated times post reconstitution, naïve corneas were excised, fixed and whole mounted onto slides for 
confocal analysis.  Data represents the mean±  SEM number of pCD11c-EGFP+ cells per 40x field, in the serial 
strips moving towards the central cornea. Field 2 and 3 are indicative of the two most central fields in the strip. Data 
is indicative of 2 independent experiments, n=6. 
 
 
7.2 LOCAL AND SYSTEMIC DT TX EFFECTIVELY ABLATES DCS FROM THE 
CORNEA  
With a corneal population identified by pCD11c-EGFP expression, our first steps were to 
establish that we can effectively ablate this population from the cornea with both a local and 
systemic treatment of DT.  Naïve CD11c-DTR mice were locally depleted via subconjunctival 
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injection or systemically with an i.p. DT treatment.  Prior studies have observed that a single 
systemic injection of DT effectively ablates CD11c+ cells for 2 days, after which recovery begins 
(227,229,230).  With this in mind, 2 days following injections, both DT treatments appeared to 
effectively remove pCD11c+ cells from the cornea (Figure 32).  A concern of treatments was the 
enhanced infiltration of PMN neutronphils or monocytes into the tissue in response to the 
inflammation by the DC ablation.  Based on CD11b+ cell infiltration into the cornea following 
treatment there was little, if any increased infiltration of CD11b+ cells into the cornea.  Within 
the naïve cornea, MHC-II+ expression is also seen on CD11b+ cells that lack pCD11c.  This is 
similar to a prior observation by our group (49).  A second concern of the local injection was the 
increase in MHC-II expression on these cells following ablation, which could alter the 
progression of the immune response to HSV-1.  As also seen in Figure 32, frequency of MCH-
II+CD11b+ cells remains similar within the cornea following local or systemic DT treatment. 
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 Figure 33 – Local or systemic Diphtheria toxin treatment effectively ablates CD11c+ cells 
from the cornea 
Naïve CD11c-DTR mice received subconjunctival injections of 50ng DT or PBS, or they received 150ng DT 
systemically via i.p. injection.  2 days following injections whole corneas were harvested, stained for antibodies to 
CD11b and MHC-II, fixed, and whole mounted for confocal microscopy.  Figure depicts representative Z-stack 
images from areas within the peripheral cornea moving out to the central corneal regions. N=3 mice per group, 
representative images from 2 independent experiments. 
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7.3 LOCAL DT TX DOES NOT ABLATE CELLS IN THE DRAINING LYMPH 
NODES 
An important concern of local DT treatment was that of leakage of toxin into the blood stream or 
down the lymphatics to the lymphoid tissues.  Leakage and subsequent depletion of DCs in 
lymphoid organs as a byproduct of a local depletion would greatly complicate interpretation of 
these findings.  Within the draining lymph nodes and spleens of CD11-DTR mice treated locally 
with DT, we saw no appreciable loss of CD11c+ cells compared to that of mock PBS treated 
controls (Figure 34A).  Of note was the observation that pCD11c-EGFP and surface CD11c+ 
cells had great concordance in expression (Figure 34B).  Systemic DT treatment completely 
ablated these cells from the lymphoid organs. As summarized in Figure 34C, local treatment 
caused no significant change in the frequency of CD11c+ in lymphoid organs, while systemic 
injections removed these cells effectively. 
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 Figure 34 – Local Diphtheria toxin treatment does not ablate systemically 
Naïve CD11c-DTR mice received subconjunctival injections of 50ng DT or PBS, or they received 150ng DT 
systemically via i.p. injection.  2 days following injections draining lymph nodes and spleens were harvested and 
dispersed into single cell suspensions, and stained for antibodies to CD11c and CD11b, and analyzed via flow 
cytometry.  A) Representative flow plots depicting CD11c+ cells within the draining lymph nodes and spleens.  B) 
Representative flow plots from the spleen depicting concordance of expression between surface CD11c and 
promoter drive EGFP.  C) Graphical representation of CD11c+ frequency in the DLN and spleen.  Data is presented 
as mean ± SEM frequency of CD11c+ cells (* p < .05, ** p < .01). n=7-9/group, 2 independent experiments. 
7.4 NK CELLS AND PLASMACYTOID DCS ARE NOT LOST FOLLOWING DT 
TREATMENT 
A number of studies have observed NK cells can express CD11c and that either NK cell 
depletion or DC depletion approaches may inadvertently remove the other population (231).  
While pDCs have not been reported to be ablated in CD11c-DTR mice, we nevertheless   
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established that this cell population remained unaffected following DT treatment in our model.  
We assayed for the secondary depletion of these two important innate arm populations in naïve 
CD11c-DTR mice systemically treated with DT.  Both populations appeared to remain intact 
following systemic DT treatment (Figure 35).  NK cells residing within the spleen did not appear 
to express significant levels of CD11c (Figure 35A, B), and no detectable loss of these cells was 
observed following treatment.  pDCs also remained stable following DT treatment;  these cells 
also appeared to be completely negative for pCD11c-EGFP (Figure 35C), correlating with 
previous studies that reported these cell populations were not altered by DT treatment (227). 
 
Figure 35 – Neither NK cells nor pDCs are affected by DT depletion of CD11c+ cells 
Naïve CD11c-DTR mice received subconjunctival injections of 50ng DT or PBS, or they received 150ng DT 
systemically via i.p. injection.  2 days following injections spleens were harvested and dispersed into single cell 
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suspensions, and stained for antibodies to CD11c and DX5, or PDCA-1, and analyzed via flow cytometry.  A) 
Gating strategy used to observe NK cell depletion; CD11c cells in red are shown in a plot showing NK cells, to 
demonstrate how few CD11c+ cells are DX5+.  B) Representative flow plots from the spleen showing no loss of NK 
cell frequency following DT treatment C) Representative flow plots depicting PDCA+ cells are not lost when 
CD11c+ cells are ablated. 
7.5 DCS WITHIN THE CORNEA ARE NOT LANGERHANS CELLS 
As discussed in this chapter’s introduction, Langerhans cells (LCs) in particular have been 
identified to have functional properties that depart from the classical understanding of how DCs 
contribute to the immune response.  Historically, all DCs within the cornea have been considered 
LCs, though few studies have used specific markers for this cell subset (133,232).  We felt it 
necessary to establish if in fact these cells were LCs, given that their potential 
immunomodulatory properties could play an important role in both the immune privileged 
cornea as well as immune control of HSV-1.  Surprisingly we did see very few Langerin+ cells 
within the cornea, in stark contrast to the skin, where these cells were readily seen (Figure 36).   
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 Figure 36 – CD11c+ cells within the cornea are not Langerhans cells 
Skin biopsies and whole corneas were harvested from CD11c-DTR mice, stained with antibodies to CD11c, fixed 
and permeabilized, stained with anti-langerin antibody, then whole mounted for confocal microscopy.  Figure 
depicts representative Z-stack reconstructions from the cornea and skin. n=2,3 mice, 2 independent experiments. 
 
More importantly LCs observed within the skin expressed no detectable EGFP, and furthermore 
they were not depleted with systemic DT treatment (data not shown).  This is similar to other 
observed studies using CD11c-DTR mice that reported poor, if any loss of LCs after DT 
treatment, despite the fact that these cells do express low levels of surface CD11c (227).  This 
data demonstrates that the classical notion LCs exist throughout the cornea were incorrect, being 
based on less accurate phenotypic markers for LCs than used here.   
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7.6 MICE LACKING DCS SYSTEMICALLY THROUGHOUT INFECTION ARE 
IMPAIRED IN VIRAL CONTROL AND HSV CD4+ T CELL RESPONSE 
After establishing our depletion model, we initiated experimentation that observe DC depletion 
in the context of ocular HSV-1 infection.  A recent study presented results that systemic DT 
treatment can impair the ability of mice to respond to HSV-1 infection (233).   This study used 
the HSV-1 resistant B6 strain of mice and also used a different route of infection (the footpad).  
We first wanted to establish how ocular HSV-1 infection is controlled in the more HSV-1 
susceptible BALB/c mice when DCs are absence throughout infection.   
When we observe mice continuously ablated of DCs throughout infection, we find there 
are serious deficiencies in both viral control and the generation of the adaptive immune response.  
In mice regularly treated with DT, we find a significant increase in viral burden within the 
cornea (Figure 37).  At 2 dpi it appears there is similar viral control (or lack thereof) regardless 
of whether the DC compartment is intact.  At 4 and 6 dpi, DC-intact mice rapidly reduce their 
viral load, which is almost non-existent by 6 dpi.  In contrast viral load is significantly higher at 
both 4 dpi and 6 dpi in DC ablated corneas.  Viral load does decline over time, suggesting that 
control is not completely lost, only impaired.  These findings demonstrate there is a significant 
impairment in the innate immune responses’ ability to control virus within the cornea while the 
adaptive immune response is being generated. 
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 Figure 37 – Mice continuously depleted of DCs have an impaired ability to control corneal 
HSV-1 infection. 
Naïve CD11c-DTR mice received subconjunctival injections of PBS or they received 150ng DT systemically via i.p. 
injection.  2 days following injections mice were ocular infected with HSV-1.  Repeat injections of PBS or DT were 
given at 3 and 6 dpi to maintain depletion.  At indicated days post infection (dpi), eyes were swabbed with a sterile 
surgical spear and assayed for live virus by standard plaque assay.  The data are presented as the mean ± SEM viral 
plaque forming units (pfu) per cornea of WT controls, locally PBS DT Tx CD11c-DTR mice, and systemically DT 
Tx mice. (** p<0.01, * p<0.05) 
 
We also observed how the adaptive immune response is generated in these mice.  When whole 
DLNs from mice systemically DT treated were stimulated with APCs loaded with HSV-1 
infected target lysate, we saw a significant impairment in the CD4+ T cell IFN-γ responses 
(Figure 38).  In response to HSV-1, CD4+ T cells from WT control mice and CD11c-DTR PBS 
mock treated mice responded with IFN-γ to HSV-1 at a frequency of ~1.5%.   Only 0.2% of 
CD4+ T cells responded with IFN-γ in DC ablated mice, close to a 10 fold reduction.  This 
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strongly suggests that the adaptive response is not effectively generated in the absence of DCs, 
which is similar to the findings of the early study that ablated DCs during HSV-1 infection (227). 
 
 
Figure 38 – Mice deficient in DCs generated a diminished HSV-1 CD4+ T cell response  
Naïve CD11c-DTR mice received subconjunctival injections of PBS or they received 150ng DT systemically via i.p. 
injection.  2 days following injections mice were ocular infected with HSV-1.  Repeat injections of PBS or DT were 
given at 3 and 6 dpi to maintain depletion.  At 7 dpi, whole DLN were harvested, and dispersed into a single cell 
suspension, and incubated for 72 hours at a 1:5 effector to target ratio with APCs pulsed with HSV-1 antigens.  
During the last 12 hours of stimulation, golgi plug was added, and cultures were subsequently stained for antibodies 
to CD4, IFN-γ, and TNF.  Graph depicts mean ± SEM frequency of CD4+ cells responding with IFN-γ only to HSV-
1 (** p < .01). n=3 mice per group, one independent experiment. 
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7.7 EARLY INFILTRATING DCS ARE NECCESARY TO FOR HSV-1 VIRAL 
CONTROL AND MOBILIATION OF THE ADAPTIVE IMMUNE RESPONSE  
We have established that removal of DCs during the entire course of infection is extremely 
detrimental to early viral control as well as the mobilization of the adaptive immune response.  
We endeavored to ask the more complex question of whether local DCs or early responding DCs 
were important to this process.  To this end, we used an approach where only a single injection 
of DT was given prior to infection.  Based on previous observations that depletion lasts 2-3 days, 
we would have recovery of DCs in treated mice by 2 dpi (4 days post injection).  We find that 
mice depleted once before infection either locally or systemically have intact DC populations 
within their lymphoid organs at 7 dpi, or 9 days after injection (Figure 39).  The two distinct DC 
populations within the spleen, CD8α+ and CD8α- DCs, are both intact after DT treatment, and in 
the case of systemic depletion, are actually almost 3 times larger in frequency then mock treated 
controls. This data does establish that DC repopulation has already occurred prior to 7 dpi, and 
that there is an intact lymphoid APC population to present antigens to T cells. 
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Figure 39 – Mice treated with DT locally or systemically prior to infection have intact 
lymphoid DCs populations at 7 dpi. 
Naïve CD11c-DTR mice received subconjunctival injections of PBS or they received 150ng DT 
systemically via i.p. injection.  2 days following injections mice were ocular infected with HSV-1.  At 7 dpi 
dispersed spleens were stained with anti-CD11b and CD11c.  Data represents representative flow plots depicting 
Cd11c+ cells recovered in the lymphoid organs.  The boxes identify CD8α+ DCs (left box) and CD8α- DCs (right 
box).  Lower panel represents EGFP+ cells and their concordant expression with surface CD11c. n=5-8 mice/group, 
2 independent experiments. 
 
When we look at the ability of these mice to control HSV-1 infection, we find that local 
depletion of DCs appeared to only have a minor impairment in viral control, while mice that 
received a systemic dose of DCs prior to infection had significant increases in viral burden 
(Figure 40).  Viral load in locally depleted mice had a moderate, but not significant elevation in 
viral burden at 4 dpi (10000 pfu/mL) when compared to mock treated controls (5000 pfu/mL), 
but went on to clear virus in similar fashion by 6 dpi.  Systemically DT treated mice had 
significantly higher levels of viral load at both 4 and 6 dpi.  Surprisingly, these mice had viral 
burden very similar to those mice whose DCs were continuously depleted throughout infection 
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(36000 pfu/mL continuous, 44000 pfu/mL single at 4 dpi and 14400 pfu/mL continuous, 10880 
pfu/mL single at 6 dpi).  This similar impairment of viral control suggests an early role for DCs 
in mobilizing the innate immune response against the corneal infection.  As locally depleted DCs 
only have a minor impairment in viral burden early, this suggests that DCs that infiltrate the 
cornea, not those present at the time of infection, contribute more towards innate control of 
HSV-1. 
 
           
Figure 40 – Mice lacking DCs systemically at the time of HSV-1 infection have impaired 
ability to control HSV-1. 
Naïve CD11c-DTR mice received subconjunctival injections of PBS or 50 ng DT, or they received 150ng DT 
systemically via i.p. injection.  2 days following injections mice were ocular infected with HSV-1.  At indicated 
days post infection (dpi), eyes were swabbed with a sterile surgical spear and assayed for live virus by standard 
plaque assay.  The data are presented as the mean ± SEM viral plaque forming units (pfu) per mL of WT controls, 
locally PBS DT Tx CD11c-DTR mice, locally DT, and systemically DT Tx mice. (* p<0.05), n=3-5 mice/group, 2 
independent experiments. 
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Also surprising was the impairment of the CD4+ T cell response to HSV-1 in 
systemically DT treated mice prior to infection.  When equivalent numbers of CD4+ T cells from 
the DLN of systemically DT treated mice were stimulated with HSV-1 at 7 dpi, they produced 
50% less IFN-γ when compared to mock treated counterparts (Figure 41).  Mice locally DT 
treated before infection had a similar response, suggesting that local resident DCs are 
dispensable for generating the adaptive immune response.   
 
 
Figure 41 – Mice lacking DCs systemically at the time of infection develop an impaired HSV-
CD4+ T cell response. 
Naïve CD11c-DTR mice received subconjunctival injections of PBS or they received 150ng DT systemically via i.p. 
injection.  2 days following injections mice were ocular infected with HSV-1.  Repeat injections of PBS or DT were 
given at 3 and 6 dpi to maintain depletion.  At 7 dpi, whole DLN were harvested, and dispersed into a single cell 
suspension, CD4+ T cells were isolated via MACS columns, and then were incubated for 72 hours at a 1:5 effector to 
target ratio with APCs pulsed with HSV-1 antigens.  At the end of the stimulation, supernatants were tested by 
standard ELISA for the IFN-γ. Graph depicts mean ± SEM pg/mL IFN-γ (* p < .05). 
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Based on these observations it appears that the DCs that infiltrate into the cornea shortly after 
infection are integral for both early viral control as well as ultimately contributing to the 
mobilization of the adaptive immune response.   
7.8 EARLY INFILTRATING DCS DIRECT MIGRATION OF NK CELLS AND 
PDCS INTO THE CENTRAL CORNEA  
Our observations that early responding DCs had such a drastic effect on viral control in the 
cornea pointed to a deficiency in the innate immune response within the cornea.  The literature  
observed that NK cells, γδ T cells, and PMNs all play a role in the initial control of HSV-l ocular 
infection(52-55), (234-236). 
Due to our approach to HSV-1 infection, viral replication will be confined to the central 
areas of the cornea.  Armed with this knowledge, we hypothesized that in mice lacking DCs one 
or more of these populations are not effectively entering the central cornea, or they are reaching 
the central cornea but are functionally deficient.  We used a 2mm trephine to remove the central 
cornea, and assayed by flow cytometry the migration of NK cells, PMNs, and inflammatory 
monocytes into the central corneas of mice treated once before infection with systemic dose of 
DT.   One can see that of the three populations assayed, inflammatory monocytes and PMNs 
make up the largest infiltrating cell populations, followed by NK cells within the cornea (Figure 
42A).   
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Figure 42- Gating Strategy for identification of innate immune responders, cornea 3 dpi 
Naïve CD11c-DTR mice received subconjunctival injections of PBS or they received 150ng DT systemically via i.p. 
injection.  2 days following injections mice were ocular infected with HSV-1.  At 3 dpi, corneas were harvested for 
flow cytometric analysis.  The central cornea was removed via a 2mm trephine, and pooled central corneas were 
dispersed, stained with mAb to CD49b (DX5), F4/80, and GR-1.  Data are representative flow plots depicting the 
gating strategy to identify PMN neutrophils, NK cells, and inflammatory monocytes. 
 
At 3 dpi, we observed that similar numbers of innate immune cells extravasate into the corneal 
periphery whether the DC compartment is ablated or intact (Figure 43).  Similar numbers of 
PMNs, inflammatory monocytes, and NK cells were observed within the peripheral cornea of 
DC ablated mice.  We see significantly fewer cells in the periphery of naïve corneas, even after 
DT treatment.  Notably, NK cells and to a greater extent inflammatory monocytes are a much 
smaller presence in the periphery of naïve corneas (Figure 43).  This agrees with the notion that 
these cells are infiltrating into the cornea in response to viral infection.  We do note an increase 
in the number PMNs in the corneas of DT Tx mice, a reflection of the lingering inflammation 
from DC ablation. 
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Figure 43 – Equivalent, or greater numbers of innate immune cells are present within the 
peripheral corneas of DT treated mice. 
Naïve CD11c-DTR mice received subconjunctival injections of PBS or they received 150ng DT systemically via i.p. 
injection.  2 days following injections mice were ocular infected with HSV-1.  At 3 dpi, corneas were harvested for 
flow cytometric analysis.  The central cornea was removed via a 2mm trephine, and peripheral corneas were 
dispersed, stained with mAb to CD49b (DX5), F4/80, and GR-1.  Graph depicts mean ± SEM absolute number of 
cells per cornea in PBS or Systemically DT Tx mice.  Dot plots below graph indicate raw flow data from 
representative samples (each 5 pooled corneas).  (n=7 samples (each 3-5 pooled corneas), 5 independent 
experiments).  
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 Figure 44 Innate immune cells are not present in large numbers in the naïve peripheral 
cornea. 
Naïve CD11c-DTR mice received subconjunctival injections of PBS or they received 150ng DT systemically via i.p. 
injection.  At 3 days post injection (which is 5 dpi for infected corneas), corneas were harvested for flow cytometric 
analysis.  The central cornea was removed via a 2mm trephine, and peripheral corneas were dispersed, stained with 
mAb to CD49b (DX5), PDCA-1, and GR-1.  Data are representative flow plots depicting the number of infiltrating 
innate immune cells into the peripheral corneas of WT controls, Mock Tx, Local DT, or systemically DT mice. Data 
is representative of 2 independent experiments, each with consisting of 5 pooled corneas. 
 
When we observe the central corneas at 3 dpi, we see significant impairment in the 
infiltration of inflammatory monocytes (2 fold reduction), and NK cells (close to a 90% 
reduction) in DT treated mice (Figure 45).  We do observe similar numbers of neutrophils within 
the central cornea following DT treatment, suggesting that only certain innate subsets were 
reliant on DCs to home to sites of viral infection.  When taken together, we conclude DCs that 
infiltrate early after infection are required to direct recently extravasated NK cells and 
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inflammatory monocytes into the central cornea.  PMNs do not appear to need local or early 
infiltrating DCs to migrate into the central cornea. 
 
 
Figure 45 – Fewer NK cells and inflammatory monocytes enter the central cornea following 
DT Treatment at 3 dpi 
 Naïve CD11c-DTR mice received subconjunctival injections of PBS or they received 150ng DT systemically via 
i.p. injection.  2 days following injections mice were ocular infected with HSV-1.  At 3 dpi, corneas were harvested 
for flow cytometric analysis.  The central cornea was removed via a 2mm trephine, and peripheral corneas were 
dispersed, stained with mAb to CD49b (DX5), F4/80, and GR-1.  Graph depicts mean ± SEM absolute number of 
cells per cornea in PBS or Systemically DT Tx mice.  Dot plots below graph indicate raw flow data from 
representative samples (5 pooled corneas).  (n=7 samples (each 3-5 pooled corneas), 5 independent experiments). * 
p < .05. 
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7.9 IFN-γ AND INOS ARE REDUCED THE CORNEAS OF DT TX MICE  
Given that we see significantly fewer NK cells and inflammatory monocytes within the central 
cornea, we would expect that we would see a corresponding loss of effector mechanisms used by 
these subsets.  NK cells, in addition to their lytic granules, have been reported to produce IFN-γ 
in response to viral infection (237).  Inflammatory monocytes are potent producers of nitric 
oxide (NO) in models of viral infection (238).  In 3 dpi corneas, we see a large upregulation of 
IFN-γ message over mock infected corneas in PBS treated mice (Figure 46).  In contrast we see 
close to 100 fold less IFN-γ message within the corneas of DT treated mice after infection.  We 
also observe a 2.5 fold less iNOS upregulation in the corneas of DT treated mice following 
infection.   Both of these observations demonstrate a reduction in critical innate effector 
mechanisms needed to combat viral infection.  Of interest was the observation that DT mice had 
impaired upregulation of IFN-γ even following mock infection of the eye (scarification, without 
the addition of virus).  This likely indicates that either resident or early responding DCs play a 
role in the innate immune response to tissue damage, in addition to viral infection.  
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 Figure 46 – IFN-γ and iNOS are reduced within the corneas of DT Tx mice at 3 dpi 
Naïve CD11c-DTR mice received subconjunctival injections of PBS or they received 150ng DT 
systemically via i.p. injection.  2 days following injections mice were ocular infected with HSV-1.  At 3 dpi, corneas 
were harvested for RNA isolation. cDNA was generated from isolated RNA, and quantitative real-time PCR was 
performed using primers to PCX (a house keeping gene), IFN-γ, and iNOS.  Data is represented as mean ± SEM 
fold differences from an unmanipulated WT cornea.  n=2 (3-4 pooled corneas) per group, 1 experiment. 
7.10 DISCUSSION – CHAPTER SEVEN 
A number of recent studies have found that peripheral DCs have divergent functions from that of 
transporting antigen to prime the adaptive immune response to invading pathogens. Notably  
epidermal resident LCs tend to play an immunomodulatory role against the immune response, 
while dermal resident LCs play classic role of mobilizing the immune system (65,66).  Here we 
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find that local resident DCs do not appear to play a major role in the mobilization of either the 
innate or adaptive immune response to HSV-1 ocular infection.  In fact, it appears that 
responding DCs that infiltrate into the cornea play a larger role in both control of virus within the 
cornea as well as initiating the adaptive immune response to HSV-1.   
The finding there was no apparent role for local resident DCs in the control of HSV-1 
infection was surprising.  Also surprising was the observation that these cells are not 
phenotypically identified as LCs, as is the established dogma in corneal immune research (156).  
A number of researchers have hypothesized that LCs within the cornea may help to play an 
immunomodulatory role in order to protect corneal immune privilege.  We saw no such change 
when we removed these cells prior to infection. Other than a minor delay in viral clearance, mice 
deficient in resident DCs ultimately clear virus and generate an adaptive immune response 
effectively.  Studies using UV irradiation of the eye in A/J mice found that that removal of DCs 
from the corneal epithelium resulted in a reduced DTH response, suggesting a diminished 
adaptive immune response was being mobilized in response to HSV-1 (239).  As the authors 
state, UV-B irradiation can ablate more than the observed DCs from the corneal epithelium.  
Depletion of other subsets along with the different strain of mouse used in these studies can 
arguably account for the differences seen in the role of local DCs seen here with our more 
specific CD11c-DTR depletion system.  A number of recent studies have found that subsets 
other then the epidermal (in our case, epithelial) LC/DCs are more important in generating the 
adaptive immune response to HSV-1 and HSV-2, which appears similar to our observations  in 
the ocular model of infection (64,67,240,241). 
 More profound were the effects when DCs were systemically depleted throughout or 
prior to HSV-1 infection.  We observed that mice deficient of DCs only early after infection 
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were equally impaired in viral control as mice lacking DCs throughout, suggesting an early role 
of recruited DCs to site of infection.  Recent studies have observed differential roles of DC 
subpopulations early after response to HSV-1 infection.  In the model of flank infection, 
epidermal LCs emigrated from the tissue rapidly following viral encounter, after which a dermal 
resident DC population accumulated around the areas of viral infection (68). A second study, 
using a model of vaginal HSV-2 infection, observed a similar sub-epithelial accumulation of 
recruited DCs to the site of infection (241).  While neither of these studies focused on the innate 
immune response, this accumulation of recruited DCs suggest these cells could be playing a local 
role in the innate immune response to viral infection. In our model, -2 dpi depleted DCs should 
recover by 2-3 days following infection; therefore DCs would be available to respond within 48 
hours following HSV-1 infection (229).  This demonstrates a critical window for DC function 
within the cornea.     
In HSV-1 ocular infection, γδ T cells, NK cells, and PMNs have all been assigned 
important roles in control of HSV-1 ocular infection (52 – 55).  We observe fewer NK cells and 
inflammatory monocytes within the central cornea following DC depletion.  Also, we observe 
significant reductions in IFN-γ and iNOS, both the primary effector mechanisms of these cells, 
respectively.  What are the potential roles DCs play in directing these cells to control virus in the 
cornea?  DC interplay with the innate immune response has been well documented.  Particularly, 
DCs have been assigned a critical role in the survival and function of NK cells by a large body of 
work (70,230,233,242).  IL-15 in particular has been identified as the primary mechanism of DC 
mediated activation of NK cell function (71).  DCs are necessary to prime NK cells in the 
lymphoid organs, after which they migrate to the periphery and exert their effector functions at 
the site of infection.  However this study observed a rapid recovery of NK cell functionality as 
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soon as DCs recovered.  In contrast, we observe impaired viral control up to a week following 
infection in mice only depleted of DCs prior to infection. Less has been established concerning a 
direct role of DCs in macrophage activation.  A number of studies have also implicated NK cells 
and their cytokines in the activation of monocytes, however (59,243).  Given our observations, it 
possible that the lack of NK cells at the site of infection results in less macrophage activation, 
and thus fewer inflammatory monocytes at the site of infection.  Further experimentations that 
remove NK cells from the cornea are required to address these hypotheses adequately.  Taken 
together, our observations suggest two possibilities: either NK cell activation by DCs is critical 
for viral control early after infection, or that a local role of DCs is needed at the site of viral 
infection.   
We believe the latter hypothesis may be correct.  We do see drastic diminishment of 
innate immune infiltration to the sites of viral replication within the cornea following DC 
ablation.  Both NK cells and inflammatory monocytes did not effectively enter the central cornea 
following systemic DT treatment.  Similar numbers of these were cells are present within the 
peripheral tissues of the cornea.  This suggests the innate immune cells are capable entering the 
cornea from the blood vessels, but are unable to migrate to the site of viral replication. In 
contrast it appears that PMN neutrophil infiltration into the central cornea was unaffected by DC 
ablation. This observation points to a different mechanism of PMN infiltration into the central 
cornea  when compared to that of NK cells and monocytes.  Given the PMN neutrophil role of 
“first responding” innate immune cells, it is reasonable that these cells have large amount of 
redundancy in their chemotactic machinery (244).  Regardless, it appears these PMN neutrophils 
present within the cornea of DC ablated mice are either unable to control viral replication alone, 
or are functionally impaired, given the high viral load within the cornea.  Both possibilities point 
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to the necessity of a combined innate immune response for control HSV-1.  We have also not 
observed whether the infiltration of γδ T cells is impeded following DC ablation.  Given their 
important role in viral control in the cornea we plan to include this subset in future 
experimentation. 
What are the potential DC directed chemokines and cytokines that direct the homing of 
these cells to the site of infection?  In the context of HSK, IL-2 has been implicated in infiltration 
of PMN neutrophils into the central cornea as well as their survival  (245).  Another study 
observed IL-6 drove MIP-1α and MIP-2 production by DCs in the cornea to promote infiltration 
of PMN neutrophils into the cornea (225).  In mice lacking CCR5, PMN neutrophil infiltration 
into the infected cornea was diminished (246).  These studies may be instructive to what is 
needed for the infiltration of inflammatory monocytes and NK cells.  Few studies observed the 
chemokines needed for NK cells and inflammatory monocyte homing within the cornea.  
However a studies in the context of other infections have implicated a large number of 
chemokines in the migration of these cells (247,248). Given the complex redundancies that exist 
in chemokine function, it is likely a large number of chemokines are produced either directly or 
indirectly by early responding DCs.  While neutrophils may be capable of infiltrating to danger 
signals and other viral replication induced factors, noted DC produced chemokines such as these 
may be integral for the proper homing of other innate immune cells to the site of infection.  
Further experimentation will be needed to dissect the role of chemokines in innate immune 
migration into the central cornea, and how local responding DCs contribute to these processes. 
We found that removal of DCs also has a dramatic effect on the adaptive immune 
response.  In continuously DC depleted mice, we saw over a tenfold decline in the frequency of 
HSV-1 reactive cells within the DLN at 7 dpi.  Viral antigen can travel directly down the 
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lymphatics directly to the DLNs, where other APCs, such as macrophages or B cells can present 
these antigens, albeit with a reduced efficiency to prime the adaptive immune response (249).  
We believe these factors could account for the remaining reactivity in continuously DC ablated 
mice.   
 In mice depleted only of DCs systemically prior to infection, we saw an approximate 
50% reduction in IFN-γ response to HSV-1 from DLN CD4+ T cells.  Given this intermediate 
impairment of the adaptive immune response, it could be that the delay in DCs in reaching the 
cornea, and presenting the antigen within the DLNs could be explain this reduction in the 
adaptive immune response.  Further study will be needed to clarify if there is an ancillary role of 
early responding DCs in the priming of the adaptive immune response, or if this is a delay in the 
kinetics of the immune response.  In either case, the adaptive immune response only contributes 
to viral control within the cornea late in the infection (6-8 dpi), suggesting against the possibility 
that deficiencies in the adaptive immune response is accounting for the viral control in the cornea 
early (37,250).  Nevertheless, this hypothesis will need to be clarified with further 
experimentation. 
To conclude this chapter, our model of DT treatment can ablate DCs to observe their role 
both temporally and spatially within the context of HSV-1 corneal infection.  We observed 
resident DCs within the cornea at the time of infection are not absolutely necessary to generate 
the adaptive immune response, although they may play a minor role in the innate directed control 
of virus early after infection.  In contrast, early recruited DCs appear to play a more important 
role in directing the innate immune response to HSV-1.  We suspect this to be a local role, which 
may be in the production of a chemotactic gradient which directs innate immune responders to 
the site of infection from the peripheral cornea.  While more experimental approaches will be 
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needed to clarify these questions, we believe that this study represents an unappreciated role of 
recruited DCs in mobilizing localized innate responses to viral infection. 
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8.0  SUMMARY AND CONCLUDING REMARKS 
The mechanisms that drive the normally protective immune response to that of a damaging 
pathology consist of a variety of complex factors.  The pathology of herpes stromal keratitis is no 
exception.  The immune response can direct a protective mechanism that minimizes viral 
replication and reactivation.  It can also drive a more damaging dysregulated immune response 
that ultimately leads to corneal blindness.   
Our group and others have observed the importance of a strong HSV-CD8 response in the 
control of HSV-1 reactivation from latently infected neurons.  Here we demonstrate CD4+ T 
cells provide important aid to these CD8+ T cells during their priming and expansion which we 
suspect regulates the threshold of TCR stimulation that causes PD-1 upregulation. This help 
allows HSV-CD8 to remain functionally competent within the TG, where these cells experience 
high levels of antigen and PD-1 ligands over a long period of time.  Thus CD4 T cells provide 
important signals that help the immune system combat HSV-1 viral infection. 
In contrast to the supporting role in the context of CD8+ T cell immunosurveillance of 
latency, CD4+ T cells are the main orchestrators of HSK.  This immune mediated disease 
overwhelms the anti-inflammatory protections in place within the cornea, resulting in 
progressive damage to corneal architecture and blindness.  Understanding why CD4+ T cells 
drive HSK is paramount to developing therapeutic treatments.  Here we identified HSV-1 
specific CD4+ T cells from the HSK-inflamed cornea.  We found that these cells responded to 
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glycoprotein B.  More importantly, we identified that while these cells retained an identical TCR, 
some cells appeared to be TH1 cells while other cells were TH17.  Unfortunately we were unable 
to demonstrate these cells were able to initiate HSK, due to differences in expression of adhesion 
molecules compared to that of effector cells in vivo.  Nevertheless our findings do raise a number 
of interesting concepts to how HSK is initiated.  The cornea microenvironment usually has large 
amounts of TGF-β, an immunomodulating cytokine. As TH1 CD4+ T cells respond to the HSV-1 
infected cornea, they encounter large amounts of TGF-β, along with inflammatory cytokines 
such as IL-6.  It is possible this combination of cytokines (known to drive differentiation of 
inflammatory TH-17 cells) might promote peripheral differentiation of non-pathogenic TH1 cells 
to pathogenic TH17 cells.  Given that TH-17 cells have been implicated in a large number of 
immunopathologies, it is reasonable that these newly minted TH-17 cells initiate the cascade of 
events that leads to HSK.  If these hypotheses hold true, we would have a situation where the 
barriers put into place by the cornea to combat excessive inflammation may, in fact, drive just 
that.  Regardless of the mechanism, here we can see two clear examples in the murine model of 
HSV-1 ocular infection where CD4+ T cells can provide both helpful and pathological signals to 
the immune response to HSV-1. 
Dendritic cells are the sentinels of the immune system as well as an important line of 
communications between the innate and adaptive immune response.  Here we observed what 
DCs do to contribute to the local innate immune response early after HSV-1 ocular infection.  
We found when DCs were removed from the cornea prior to infection viral control was impaired 
during the first week of infection.  In the absence of DCs, certain innate immune responders, 
notably inflammatory monocytes and NK cells were unable to traffic from the peripheral cornea 
to the sites of viral infection in the central cornea.  We hypothesize that DCs must respond early 
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to infection in order to drive the production of the chemokine gradient the innate immune 
response requires to home to sites of infection in situ. This data forwards a concept where in 
addition to their role in activating the adaptive immune response, DCs can play a local role in 
directing the innate immune response at the site of infection.   
A number of studies have also implicated APCs in helping to drive HSK.  Here we found 
that IL-12p70, a cytokine classically produced by APCs, is important for HSK.  We find that 
mice lacking the subunit IL-12p35 develop transient HSK.  These observations hold true even 
when mice lack both IL-12p35 and p40.  In mice lacking IL-12p35 we see significant reductions 
in soluble factors important for HSK (VEGF, MCP-1, and KC). Based on these findings we 
conclude IL-12p35 is operating in an IL-12p40 independent fashion that contributes to HSK 
progression.  While we did not establish DCs were the source of this cytokine, a large body of 
work would indicate APCs, whether DCs or macrophages, are the probable source of these 
cytokines.  Here, as with CD4+ T cells, we see that DCs can also aid in controlling viral 
replication or assist in immunopathology in response to HSV-1.   
A large number of immune-mediated diseases exist within the clinic; only through 
enhanced understanding of both the protective and pathogenic roles of infiltrating can we better 
understand these diseases and devise effective therapy.  When it comes to ocular HSV-1 
infection, we must be cautious that attempts to enhance immune surveillance of latently infected 
neurons do not lead to exacerbation of immunopathology in the infected cornea.    A better 
understanding of the mechanisms of HSK and immune protection from HSV-1 reactivation from 
latency will enhance prospects for developing therapeutic vaccines capable of enhancing 
protection while minimizing immunopathology.  .   In the context of this body of work, 
understanding CD4+ T cell and DC functions help further us along our path of understanding 
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both the beneficial and detrimental effects of the immune response to HSV-1.  This data and the 
studies it will lead to not only allow us to better design therapeutic vaccines to HSV-1 and 
potentially HSK, but contribute to the understanding of the immune response in a general 
fashion.  This will help provide the building blocks other models of infection can use to 
understand their respective mechanisms of immune control and pathogenesis. 
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